CA2157634C - Hydrogel intervertebral disc nucleus - Google Patents
Hydrogel intervertebral disc nucleus Download PDFInfo
- Publication number
- CA2157634C CA2157634C CA002157634A CA2157634A CA2157634C CA 2157634 C CA2157634 C CA 2157634C CA 002157634 A CA002157634 A CA 002157634A CA 2157634 A CA2157634 A CA 2157634A CA 2157634 C CA2157634 C CA 2157634C
- Authority
- CA
- Canada
- Prior art keywords
- nucleus
- hydrogel
- disc
- prosthetic nucleus
- cavity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 94
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 45
- 210000001124 body fluid Anatomy 0.000 claims abstract description 6
- 239000010839 body fluid Substances 0.000 claims abstract description 6
- 239000000178 monomer Substances 0.000 claims description 16
- 239000007943 implant Substances 0.000 claims description 14
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 11
- 238000002513 implantation Methods 0.000 claims description 9
- 239000012530 fluid Substances 0.000 claims description 7
- 101100457461 Caenorhabditis elegans mnm-2 gene Proteins 0.000 claims description 6
- 229920001577 copolymer Polymers 0.000 claims description 6
- 230000036571 hydration Effects 0.000 claims description 6
- 238000006703 hydration reaction Methods 0.000 claims description 6
- SJIXRGNQPBQWMK-UHFFFAOYSA-N 2-(diethylamino)ethyl 2-methylprop-2-enoate Chemical group CCN(CC)CCOC(=O)C(C)=C SJIXRGNQPBQWMK-UHFFFAOYSA-N 0.000 claims description 5
- 238000004132 cross linking Methods 0.000 claims description 5
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical group C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- -1 hydroxyalkyl acrylates Chemical class 0.000 claims description 4
- 229920002554 vinyl polymer Polymers 0.000 claims description 4
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical group FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 claims description 3
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical group CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims description 3
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 3
- 238000003780 insertion Methods 0.000 claims description 3
- 230000037431 insertion Effects 0.000 claims description 3
- 150000002734 metacrylic acid derivatives Chemical class 0.000 claims description 3
- 229920001519 homopolymer Polymers 0.000 claims description 2
- 229920002239 polyacrylonitrile Polymers 0.000 claims description 2
- 238000007334 copolymerization reaction Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 22
- 239000000499 gel Substances 0.000 description 14
- 239000000463 material Substances 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 230000008901 benefit Effects 0.000 description 12
- 239000000835 fiber Substances 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 102000016611 Proteoglycans Human genes 0.000 description 10
- 108010067787 Proteoglycans Proteins 0.000 description 10
- 230000008961 swelling Effects 0.000 description 9
- 102000008186 Collagen Human genes 0.000 description 8
- 108010035532 Collagen Proteins 0.000 description 8
- 229920001436 collagen Polymers 0.000 description 8
- 230000007423 decrease Effects 0.000 description 7
- 208000008035 Back Pain Diseases 0.000 description 6
- 238000011068 loading method Methods 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 208000008930 Low Back Pain Diseases 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 229920001287 Chondroitin sulfate Polymers 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 102000011782 Keratins Human genes 0.000 description 3
- 108010076876 Keratins Proteins 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 230000007850 degeneration Effects 0.000 description 3
- 230000032798 delamination Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000011824 nuclear material Substances 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229910021653 sulphate ion Inorganic materials 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 2
- 206010061246 Intervertebral disc degeneration Diseases 0.000 description 2
- 241000446313 Lamella Species 0.000 description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000002706 hydrostatic effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 229920006030 multiblock copolymer Polymers 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 210000001032 spinal nerve Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010050296 Intervertebral disc protrusion Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 229920001616 Polymacon Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 208000018180 degenerative disc disease Diseases 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940093476 ethylene glycol Drugs 0.000 description 1
- 230000006355 external stress Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000003035 hyaline cartilage Anatomy 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000021600 intervertebral disc degenerative disease Diseases 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 238000010128 melt processing Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 210000003497 sciatic nerve Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010129 solution processing Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 230000009974 thixotropic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000002517 zygapophyseal joint Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/441—Joints for the spine, e.g. vertebrae, spinal discs made of inflatable pockets or chambers filled with fluid, e.g. with hydrogel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/30199—Three-dimensional shapes
- A61F2002/30291—Three-dimensional shapes spirally-coiled, i.e. having a 2D spiral cross-section
- A61F2002/30298—Parallelepipedal body made by spirally rolling up a sheet or a strip around itself
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
- A61F2002/4435—Support means or repair of the natural disc wall, i.e. annulus, e.g. using plates, membranes or meshes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
- A61F2002/444—Intervertebral or spinal discs, e.g. resilient for replacing the nucleus pulposus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0091—Three-dimensional shapes helically-coiled or spirally-coiled, i.e. having a 2-D spiral cross-section
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/902—Method of implanting
- Y10S623/908—Bone
Abstract
An article for use in the preparation of a hydrogel prosthetic nucleus, for an intervertebral disc, having equilibrium water contents (EWCs) of from about 30 to about 90 % and compressive strengths of at least 4 meganewtons per square meter (MNm-2), at their EWCs, when subjected to the same constraints as the normal nucleus, comprising one or more xerogel rods containing from zero to less than the EWC. Amethod for preparing a hydrogel prosthetic nucleus, for a vertebral disc, comprising one or more hydrogel rods containing from about 30 to about 90 % water, and having compressive strengths of at least 1 MNm-2, at their EWCs, which comprises inserting one or more hydrophilic xerogel rods, which at their EWC will contain from about 30 to about 90 % water and have compressive strengths of at least 1 MNm-2, containing water in an amount from about zero to less than their EWC, into the cavity of the disc through an opening in its annulus and allowing the rod, or rods, to absorb sufficient water from the body fluids to attain their EWCs and essentially fill the intervertebral nuclear disc cavity.
Description
215"~~a~
_1 _ HYDROGEL INTERVERTEBRAL DISC NUCLEUS
BACKGROUND OF THE INVENTION
Field of the Invention This invention relates to a prosthetic intervertebral disc nucleus. More particularly it relates to an artificial disc nucleus made of a hydrogel material.
The intervertebral disc is a complex joint anatomically and functionally. It is composed of three component structures: the nucleus pulposus (the nucleus), the annulus fibroses (the annulus) and the vertebral end-plates. The biochemical composition and anatomical arrangements within these component structures are related to the biomechanical function of the disc.
The nucleus occupies about 25-4090 of the total disc cross-sectional area. It is primarily composed of mucoid material containing mainly proteoglycans with a small amount of collagen. The proteoglycans consist of a protein core with chains of negatively charged keratin sulphate and chondroitin sulphate covalently attached thereto. Due to these constituents, the nucleus is a loose hydrogel which usually contains about 70-9096 water by weight. Although the nucleus plays an important role in the biomechanical function of the disc, the mechanical properties of the disc are not well known, largely because of the loose hydrogel nature of the nucleus.
As the nucleus is surrounded by the annulus and vertebral end-plates, and the negatively charged sulphate groups are immobilized due to the attachment of these groups to the polymer matrix, the matrix has a higher concentration of counter ions than its surroundings. This ion concentration results in a higher osmotic pressure than the annulus e.g., ranging from about 0.1 to about 0.3 MPa. As a result of the high fixed charge density of the proteoglycan the matrix exerts an osmotic swelling pressure which can support an applied load in much the same way as air pressure in a tire supports the weight of a car.
It is the osmotic swelling pressure and hydrophilic'ity of the nucleus matrix that offers the nucleus the capability of imbibing fluid until it is balanced with the internal resistance stresses, due to the tensile forces of the collagen network, and the external stresses due to the loads that are applied by muscle and ligament tension. The swelling pressure (Ps) of the nucleus is directly dependent on the concentration and fixed charge densities of proteoglycan, i.e., the higher the concentration and fixed charge densities of proteoglycan the higher will be the swelling pressure of the nucleus.
_1 _ HYDROGEL INTERVERTEBRAL DISC NUCLEUS
BACKGROUND OF THE INVENTION
Field of the Invention This invention relates to a prosthetic intervertebral disc nucleus. More particularly it relates to an artificial disc nucleus made of a hydrogel material.
The intervertebral disc is a complex joint anatomically and functionally. It is composed of three component structures: the nucleus pulposus (the nucleus), the annulus fibroses (the annulus) and the vertebral end-plates. The biochemical composition and anatomical arrangements within these component structures are related to the biomechanical function of the disc.
The nucleus occupies about 25-4090 of the total disc cross-sectional area. It is primarily composed of mucoid material containing mainly proteoglycans with a small amount of collagen. The proteoglycans consist of a protein core with chains of negatively charged keratin sulphate and chondroitin sulphate covalently attached thereto. Due to these constituents, the nucleus is a loose hydrogel which usually contains about 70-9096 water by weight. Although the nucleus plays an important role in the biomechanical function of the disc, the mechanical properties of the disc are not well known, largely because of the loose hydrogel nature of the nucleus.
As the nucleus is surrounded by the annulus and vertebral end-plates, and the negatively charged sulphate groups are immobilized due to the attachment of these groups to the polymer matrix, the matrix has a higher concentration of counter ions than its surroundings. This ion concentration results in a higher osmotic pressure than the annulus e.g., ranging from about 0.1 to about 0.3 MPa. As a result of the high fixed charge density of the proteoglycan the matrix exerts an osmotic swelling pressure which can support an applied load in much the same way as air pressure in a tire supports the weight of a car.
It is the osmotic swelling pressure and hydrophilic'ity of the nucleus matrix that offers the nucleus the capability of imbibing fluid until it is balanced with the internal resistance stresses, due to the tensile forces of the collagen network, and the external stresses due to the loads that are applied by muscle and ligament tension. The swelling pressure (Ps) of the nucleus is directly dependent on the concentration and fixed charge densities of proteoglycan, i.e., the higher the concentration and fixed charge densities of proteoglycan the higher will be the swelling pressure of the nucleus.
The external pressure changes with posture. When the human body is supine the compressive load on the third lumbar disc is 300 newtons (N) which rises to when an upright stance is assumed. The compressive load increases, yet again, to 1200 N when the body is bent forward by only 20°. When the external pressure (Pa) increases the previous balance, i.e., Ps = Pa, is upset. To reach a new balance the swelling pressure has to increase. This increase is achieved by increasing the proteoglycan concentration in the nucleus which is achieved by reducing the fluid in the nucleus. That is why discs lose about 1096 of their height, as a result of creep, during the daytime. When the external load is released i.e., Ps is greater than Pa, the nucleus will imbibe fluid from its surroundings in order to reach the new equilibrium value. It is this property of the nucleus that is mainly responsible for the compressive properties of the disc.
The annulus forms the outer limiting boundary of the disc. It is composed of highly structured collagen fibers embedded in an amorphous base substance which is also composed of water and proteoglycans. The amount of proteoglycans is lower in the annulus than in the nucleus. The collagen fibers of the annulus are arranged in concentric laminated bands or lamella, (about 8-12 layers thick) with a thicker anterior wall and thinner posterior wall. In each lamella, the fibers are parallel and attached to the superior and inferior vertebral bodies at an angle of about 30°
from the horizontal plane of the disc in both directions. This design particularly resists twisting because the half of the fibers cocked in one direction will tighten as the vertebrae rotate relative to each other in the other direction. *The composition of the annulus along the radial axis is not uniform. There is a steady increase in the proportion of collagen from the inner to the outer sections of the annulus. This difference in composition may reflect the need of the inner and outer regions of the annulus to blend into very different tissues while maintaining the strength of the structure. Only the inner lamellae are anchored to the end-plates forming an enclosed vessel for the nucleus. The collagen network of the annulus restrains the tendency of the nucleus gel to absorb water from surrounding tissues and swell. Thus, the collagen fibers in the annulus are always in tension, and the nucleus gel is always in compression.
The two vertebral end=plates are composed of hyaline cartilage, which is a clear, 'glassyu tissue, that separates the disc from the adjacent vertebral bodies.
This layer acts as a transitional zone between the hard, bony vertebral bodies and the soft disc.
21~'~~~~
The annulus forms the outer limiting boundary of the disc. It is composed of highly structured collagen fibers embedded in an amorphous base substance which is also composed of water and proteoglycans. The amount of proteoglycans is lower in the annulus than in the nucleus. The collagen fibers of the annulus are arranged in concentric laminated bands or lamella, (about 8-12 layers thick) with a thicker anterior wall and thinner posterior wall. In each lamella, the fibers are parallel and attached to the superior and inferior vertebral bodies at an angle of about 30°
from the horizontal plane of the disc in both directions. This design particularly resists twisting because the half of the fibers cocked in one direction will tighten as the vertebrae rotate relative to each other in the other direction. *The composition of the annulus along the radial axis is not uniform. There is a steady increase in the proportion of collagen from the inner to the outer sections of the annulus. This difference in composition may reflect the need of the inner and outer regions of the annulus to blend into very different tissues while maintaining the strength of the structure. Only the inner lamellae are anchored to the end-plates forming an enclosed vessel for the nucleus. The collagen network of the annulus restrains the tendency of the nucleus gel to absorb water from surrounding tissues and swell. Thus, the collagen fibers in the annulus are always in tension, and the nucleus gel is always in compression.
The two vertebral end=plates are composed of hyaline cartilage, which is a clear, 'glassyu tissue, that separates the disc from the adjacent vertebral bodies.
This layer acts as a transitional zone between the hard, bony vertebral bodies and the soft disc.
21~'~~~~
Because the intervertebral disc is avascular, most nutrients that the disc needs for metabolism are transported to the disc by diffusion through the end-plate area.
The intervertebral joint exhibits both elastic and viscous behavior. Hence, during the application of a load to the disc there will be an immediate "distortion"
or "deformation" of the disc, often referred to as "instantaneous deformation".
It has been reported that the major pathway by which water is lost, from the disc during compression, is through the cartilage end-plates. Since the water permeability of the end-plates is in the range of about 0.20 to about 0.85 x 10'" m4 N'' sec'' it is reasonable to assume that under loading, the initial volume of the disc is constant while the load is applied. Because the natural nucleus of the disc is in the form of a loose hydrogel, i.e., a hydrophilic polymeric material which is insoluble in water, it can be deformed easily, the extent of deformation of the disc being largely dependent on the extensibility of the annulus. It is generally believed that the hydrostatic behavior of the nucleus plays an important role in the normal static and dynamic load-sharing capability of the disc and the restoring force of the stretched fibers of the annulus balances the effects of the nucleus swelling pressure. Without the constraint by the annulus, annular bulging of the nucleus would increase considerably. If the load is maintained at a constant level, a gradual change in joint height, commonly referred to as "creep" will occur as a function of time. Eventually, the creep will stabilize and the joint is said to be in "equilibrium". When the load is removed the joint will gradually 'recover" to its original height before loading. The creep and relaxation rates depend on the amount of load applied, the permeability of the end-plates and the water binding capability of the nucleus hydrogel. Creep and relaxation are essential processes in pumping fluid in and out of the disc.
Degeneration of the intervertebral disc is believed to be a common cause of final pathological changes and back pain. As the intervertebral disc ages it undergoes degeneration. The changes that occur are such that, in many respects, the composition of the nucleus seems to approach that of the inner annulus.
Intervertebral disc degeneration is, at least in part, the consequence of compositional changes in the nucleus. It has been found that both the molecular weight and the amount of proteoglycans in the nucleus decrease with age, especially in degenerated discs, and the ratio of keratin sulphate to chondroitin sulphate in the nucleus increases. This increase in the ratio of keratin sulphate to chondroitin sulphate and decrease in 2~.~7~~~
proteoglycan content decreases the fixed charge density of the nucleus from about 0.28 meq/ml to about 0.18 - 0.20 meq/ml. These changes cause the nucleus to lose part of its water binding capability which decreases the maximum swelling pressure it can exert. As a result, the maximum water content drops from over about 8596, in preadolescence, to about 70-75~ in middle age. The glycosaminoglycan content of prolapsed discs has been found to be lower, and the collagen content higher, than that of normal discs of a comparable age. Discs L-4 - L-5 and L-5 - S-1 are usually the most degenerated discs.
It is known that although the nucleus only occupies about one third of the total disc area, it takes about 70~ of the total loading in a normal disc. Thus, it has been found that the compressive load on the nuclei of moderately degenerated discs is about 30°~ lower than in comparable normal discs but the compressive load on the annulus increases by 10096 in the degenerated discs. This load change is primarily caused by the structural changes in the disc as discussed above. The excess load on the annulus, of the degenerated disc, causes reduction of the disc height and excessive movement of the spinal segments. The flexibility of the disc produces excessive movement of the collagenous fibers which, in turn, injures the fiber attachments and causes delamination of the well organized fibers of the annulus ring. The delaminated annulus can be further weakened by stress on the annulus and in severe cases this stress will cause tearing of the annulus. This whole process is very similar to driving on a flat tire, where the reinforcement layer will eventually delaminate.
Because the thickness of the annulus is not uniform, with the posterior portions being thinner than the anterior portions, delamination and lesions usually occur in the posterior area first.
The spinal disc may also be displaced or damaged due to trauma or diseases.
In these cases, and in the case of disc degeneration, the nucleus may hemiate and/or protrude into the vertebral canal or intervertebral foramen, in which case it is known as a herniated or "slipped" disc. This disc may in tum press upon the spinal nerve that exits the vertebral canal through the partially obstructed foramen, causing pain or paralysis in the area of its distribution. The most frequent site of occurrence of a hemiated disc is in the lower lumbar region. A disc hemiation in this area often involves the inferior extremities by compressing the sciatic nerve.
There are basically three types of treatment currently being used for treating low back pain caused by injured or degenerated discs: conservative care, discectomy and ~1~'~G'4 fusion. Each of these treatments has its advantages and limitations. The vast majority of patients with low back pain, especially those with first time episodes of low back pain, will get better with conservative care treatment. However, it is not necessarily true that conservative care is the most efficient and economical way to solve the low back pain problem.
Discectomy usually provides excellent short term results in relieving the clinical symptoms, by removing the herniated disc material, usually the nucleus, which causes < the low back pain either by compressing the spinal nerve or by chemical irritation.
Clearly, a discectomy is not desirable from a biomechanical point of view. In a healthy disc, the nucleus takes the most compressional load and in a degenerated disc this load is primarily distributed onto the annulus ring which, as described above, causes tearing and delamination of the annulus. Removal of the nucleus in a discectomy actually causes distribution the compressive load onto the annulus ring thereby narrowing the disc spaces. It has been reported that a long-term disc height decrease might be expected to cause irreversible osteoarthritis-like changes in the facet joint.
That is why discectomy yields poor long term benefits and results in a high incidence of reherniation.
Fusion generally does a good job in eliminating symptoms and stabilizing the joint. However, because the motion of the fused segment is restricted, the range of motion of the adjoining vertebral discs is increased possibly enhancing their degenerative processes.
Because of these disadvantages, it is desirable to use a prosthetic joint device which not only is able to replace the injured or degenerated intervertebral disc, but also can mimic the physiological and the biomechanical function of the replaced disc. Such a device would restore the normal functions of the disc and prevent further degeneration of the surrounding tissue.
Description of the Prior Art Artificial discs are well known in the prior art. United States Patent 3,867,728, to Stubstad et al., relates to a device which replaces the entire disc. This device is made by laminating vertical, horizontal or axial sheets of elastic polymer.
U.S. Patent 3,875,595 to Froning relates to a collapsible plastic bladder-like prosthesis of nucleus pulposus. U.S. Patent 4,309,777, to Patil, relates to a prosthesis utilizing metal springs and cups. A spinal implant comprising a rigid solid body. having a porous coating on part of its surface is shown in Kenna's U.S. Patent 4,714,469. An intervertebral disc prosthesis consisting of a pair of rigid plugs to replace the degenerated disc is referred by Kuntz, United States Patent 4,349,921. United States Patents 4,772,287 and 4,904,260, to Ray et al., teach the use of a pair of cylindrical prosthetic intervertebral disc capsules with or without therapeutical agents. U.S. Patent 4,911,718, to Lee et al., relates to an elastomeric disc spacer comprising three different parts;
nucleus, annulus and end-plates, of different materials. At the present time, none of these inventions has become a product in the spinal care market. Bao et al., in United States Patent Nos. 5,047,055 and 5,192,326 (assigned to the assignee of this invention) describe artificial nuclei comprising hydrogels in the form of large pieces shaped to conform to the shape of the disc cavity or beads within a porous envelope, respectively. The hydroge~ls have an equilibrium water content (EWC) of at least about 30% and a compressive strength of at least about 1 meganewtons per square meter (1 MNrri Z) when subjected to the constraints of the annulus and end plates of the disc. Preferably, the compressive strength of the nucleus is about 4 MNm-Z.
The primary disadvantage of the inventions of Stubstad et al., Patil, Kenna and Lee et al. is that use of their prostheses requires complete replacement of the natural disc which involves numerous surgical difficulties. Secondly, the intervertebral disc is a complex joint, anatomically and functionally, comprising the aforementioned three component structures, each of which has its own unique structural characteristics.
Designing and fabricating such a complicated prosthesis from acceptable materials, which will mimic the function of the natural disc:, is very difficult. A
further problem is the difficulty of preventing the prosthesis from dislodging. Fourthly, even for prostheses which are only intended for replacing the nucls~us, a major obstacle has been to find a material which is similar to the natural nucleus and is also able to restore the normal function of the nucleus. Hydrophobic elastome~rs and thermoplastic polymers are not desirable for use in the prosthetic nuclei due i:o their significant inherent differences from the natural nucleus e.g.; lack of hydrophilicity, in the elastomers, and lack of flexibility in the thermoplasts.
These problems are not solved by KuntJc, who uses elastic rubber plugs, or by Froning and Ray et al., who use bladders, or capsules, respectively, which are filled with a fluid or thixotropic gel. According to the Ray and Froning patents, liquid was ~1~'~u3~
used to fill the capsules and bladders, respectively, thereby requiring that their membranes be completely sealed to prevent fluid leakage. As a consequence, those devices cannot completely restore the function of the nucleus which allows body fluid to diffuse in and out during cyclic loading thereby providing the nutrients the disc needs.
The Bao et al., prosthetic lumbar disc nuclei are made ftom hydrogels.
Hydrogels have been used in biomedical applications, such as contact lenses.
Among the advantages of hydrogels is that they are more biocompatible than hydrophobic elastomers and metals. This biocompatibility is largely due to the unique characteristics of hydrogels in that they are soft and contain water like the surrounding tissues and have relatively low frictional coeffients with respect to the surrounding tissues. The biocompatibility of hydrogels results in prosthetic nuclei which are more easily tolerated in the body. Furthermore, hydrophobic elastomeric and metallic gels will not permit diffusion of aqueous compositions, and their solutes, therethrough.
An additional advantage of some hydrogels is their good mechanical strength which permits them to withstand the load on the disc and restore the normal space between the vertebral bodies. The aforementioned nuclei of Bao et al. have high mechanical strength and are able to withstand the body loads and assist in the healing of the defective annuli.
Other advantages of the hydrogels, used in the Bao et al. nuclei, are their excellent viscoelastic properties and shape memory. Hydrogels contain a large amount of water which acts as a plasticizer. Part of the water is available as free water which has more freedom to leave the hydrogel when the hydrogel is partially dehydrated under mechanical pressure. This characteristic of the hydrogels enables them to creep, in the same way as the natural nucleus, under compression, and to withstand cyclic loading for long periods without any significant degradation or loss of their elasticity.
This is because water in the hydrogel behaves like a cushion whereby the polymeric network of a hydrogel with a high EWC is less susceptible to damage under mechanical load.
Another advantage of hydrogels is their permeability to water and water-soluble substances, such as nutrients, metabolites and the like. It is known that body fluid diffusion, under cyclic loading, is the major source of nutrients to the natural disc. If __ 2 ~~'~1~~~
_$_ the route of this nutrient diffusion is blocked, e.g., by a water-impermeable nucleus, further deterioration of the disc will ensue.
Hydrogels can be dehydrated and the resultant xerogels hydrated again without changing the properties of the hydrogels. When a hydrogel is dehydrated, its volume decreases, thereby facilitating implantation of the prosthetic nucleus into the nuclear cavity in the disc. The implanted prosthetic nucleus will then swell, in the body, by absorption of body fluid up to its EWC. . The EWC of a hydrogel depends on the compressive load applied thereto. Thus, the EWC of a specific hydrogel in an open container will differ from the EWC of the same hydrogel in a closed vessel such as an intervertabral disc. The EWC values, referred to below, are for hydrogels subjected to compressive loads under the conditions found in an intervertebral disc. The expansion factor of a dehydrated hydrogel, in turn, is dependent on its EWC. Thus, it may vary from 1.19 for a hydrogel of 38% EWC to 1.73 for a hydrogel of 80~ EWC. For an 80~
EWC hydrogel, the volume of the dehydrated prosthetic nucleus is usually about of that of the hydrated one. The ability to be dehydrated and then return to its original shape upon hydration, up to its EWC, makes it possible to implant the device posterior-laterally during surgery, thereby reducing the complexity and risk of intraspinal surgery as traditionally used. The danger of perforation of the nerve, dural sac, arteries and other organs is also reduced. In addition, the incision area on the annulus can be reduced, thereby helping to heal the annulus and prevent the reherniation of the disc.
Hydrogels are also useful for drug delivery into the disc due to their capability for controlled release of drugs. Various therapeutic agents, such as growth factors, long term analgesics and anti-inflammatory agents can attach to the prosthetic nucleus and be released in a controllable rate after implantation of the nucleus in the disc..
Furthermore, dimensional integrity can be maintained with hydrogels having a water content of up to about 90~°. This dimensional integrity, if the nucleus is properly designed, will aid in distributing the vertebral load to a larger area on the annulus ring and prevent the prosthetic nucleus from bulging and hemiating.
However, it is normally difficult to implant a fully hydrated hydrogel prosthesis in the cavity, of a disc, through the small window provided in the disc, for removing the herniated nucleus, especially in a percutaneous surgery by virtue of their bulkiness in a fully hydrated state. Therefore, such prostheses must be implanted, in the disc in relatively dehydrated states which requires long periods to achieve their EWCs due to _ g _ their low surface areas. Other hydrogels, having high surface areas, do not completely conform t:o the shape of the nuclear cavity.
It has been found that t:he hydrogel prosthetic nuclei of the present invention, and the method for their preparation, overcome the disadvantages of the prior art prosthetic nuclei.
SUMMARY OF THE INVENTION
In the following description of the invention the term "partially hydrated xerogel" refers to a hydrophilic xerogel which has absorbed water t:o an extent less than its EWC under its expected conditions of use.
The present invention relates to a hydrogel prosthetic nucleus which may be implanted in the nuclear cavity, of an intervertebral disc, as one or more xerogel rods or tubes which may be partially hydrated. The prosthetic nucleus of the invention may be brought to its EWC more rapidly than the hydrogel prostheses of the prior art due to its greater surface area and its ability to retain its shape without the support of a container such as the envelope required in the case of nuclei foamed from hydrogel beads.
The prosthetic nucleus :is prepared from one or more pieces of hydrophilic xerogel material, in the form of rods or tubes, which in their final, fully hydrated state, will essentially completely fill the nucleus cavity in the disc.
Utilizing the hydrogel material i:n the form of the rod or tube facilitates implantation which ca:n be effected with the nuclear material in a partially hydrated state.
- 9a -One advantage of the pro sthetic nuclei of the present invention is the decrease in the time for rehydration, in the body, by virtue of their high surface areas.
Other advantages of the invention are the lack of the need for forming the xerogel in the shape of the cavity or enclosing the xerogel, in the fornn of beads, in an envelope comprising a semipermeable membrane or inserting the prosthesis into the cavity in a dehydrated or nearly dehydrated state. The implant of the invention, to the contrary, may be inserted into the' disc cavity in a partially hydrated state with the concomitant advantages enumerated above.
Thus, the prosthetic nu<:leus, of the present invention, may be inserted into the cavity in its partially hydrated form since the cross-seci:ional diameter of the partially hydrated rod is typically small, e.g., between about 2 and about 10 mm, more preferably between about 4 and 8 mm.
However, if the diameter of the rod is too small it may be reextruded from the cavity upon the _ ?~.~'~~3~
-, 0-application of pressure thereto whereas a very large diameter would make implantation of the rod, through the window, difficult. Nevertheless, a.slight excess in the diameter of the rod can be tolerated since, in the hydrated form, the diameter of the rod may be reduced by stretching. Furthermore, the probability of reextrusion of the implant is reduced since the implant comprises a long rod.
After hydration of the hydrogel tube or rod to its EWC, in the disc, the expanded tube or rod will essentially fill the cavity, from which the natural nucleus had been excised, and be constrained tightly therein by the annulus and end plates. The constraining forces are the restoring force of the stretched fibers of the annulus and the external force through the end-plates which will restrict the movement of the hydrogel nucleus and prevent it from bulging and hemiating from the cavity.
Another advantage of this invention is the quick restoration of the biomechanical functions of the disc which depend on the degree of hydration of the implant.
It is an object of the invention to provide a prosthetic nucleus for a disc which functions in a manner similar to that of the natural nucleus.
It is yet another object of the invention to provide a prosthetic nucleus for a disc which is composed of a hydrogel material capable of balancing its hydrostatic pressure with external loads thereon.
It is another object of the invention to provide a prosthetic nucleus, as described above, wherein said hydrogel is implanted as a rod or hollow tube.
Another object of the invention is to provide a hydrogel prosthetic nucleus having an EWC, when subjected to the constraints of the annulus and end plates of the disc, of about 30 to about 9096, preferably about 60-8096, and a compressive strength of at least about 1 MNrri ~ under normal constraints wherein said prosthetic nucleus comprises one or more hydrogel rods or tubes. Preferably, the compressive strength of the nucleus is about 4 MNrri Z.
These and other objects and advantages of the present invention will become apparent from the following description and the accompanying drawings, which disclose a preferred embodiment of the invention. It is to be understood that the drawings are to be used for the purposes of illustration only and not as a limitation on the scope of the invention.
BRIEF DESCRIPTION OF THE DRAWINGS
In the drawings wherein similar reference characters denote similar elements throughout: the several views:
FIG. 1 is an elevationa:L view, of a vertebral disc, absent its nucleus, with its associated vertebrae.
FIG. 2 is an elevationa:L view of an intervertebral disc and associated vertebrae, of FIG. 1, from the nucleus has been removed.
FIG. 3 is an elevationa:L view, of the disc of FIG. 2 with the partially hydrated xerogf~l prosthetic nucleus of the present invention being implanted therein.
FIG. 4 is an elevationa:L view of the disc of FIG. 2 showing the prosthetic nucleus of the present invention in the partially hydrated state.
FIG. 5 is an elevationa:l view of the disc and nuclear material of FIG. 3 wherein the tail end of the hydrogel rod has been inserted into the nuclear cavity.
FIG. 6 is an elevationa:l view of the disc and nuclear material of FIG. 3 wherein the hydrogel has absorbed water, to its EWC, expanded to it;s maximum size and filled the nuclear cavity.
DESCRIPTION OF THE PREFERRED EMBODIMENT
Referring to FIGS. 1 through 3, in the preferred embodiment the hydrogel prostheti~~ nucleus of the present invention, generally denoted as 10, conforms, when hydrated to its EWC, to the general shape of 'the natural nucleus. The prosthetic nucleus is implanted i:n the disc 12 of the vertebrae 14 and is surrounded by the natural annulus 16.
Vertebral end plates 20 and 22, as shown in FIG. 1, cover the superior and inferior faces of nuc;leus 10 respectively.
Hydrogels useful in the practice of the invention include lightly cross-linked biocompatible homopolymers and copolymers of hydrophilic monomers such as 2-hydroxyalkyl acrylates and methacrylates, e.g., 2-hydroxyethyl methacrylate (HEMA); N-vinyl monomers, for exannple, N-vinyl-2-pyrrolidone (N-VP); ethylenically unsaturated acids, for example, methacrylic acid (MA) and ethylenically unsaturated bases such as 2-(diethylamino)ethyl methacrylate (DEAEMA). The copolymers may further include residues from non-hydrophilic monomers such as alkyl methacrylat:es, for example, methyl methacrylate (MMA), and the like. The cross-linking polymers are formed, by known methods, in the presence of cross-linking agents, containing at least two et~hylenically unsaturated sites, such as ethyleneglycol dimethacrylate and methylenebis(acrylamide), and inii~iators such as 2,2-azobis(isobutyronitrile), benzoyl peroxide, and the like, and radiation such as W and 'y-ray.
Methods for the preparai~ion of these polymers and copolymers is well known to the a:rt. The EWC of these TM
hydrogels can vary, e.g., from about 38% for Polymacon (poly HEMA) to about 79% for Lidofilcon~M B (a copolymer of N-VP and MMA) under ambient conditions.
Another type of hydroge:L, useful in the practice of the invention, is illustrated by 13YPANTM and polyvinyl alcohol) (PVA) hydrogels. These :hydrogels, unlike the aforementioned hydrogels, are not cross-linked. Their insolubility in aqueous media is due to their partially crystalline structures. HYPANTM is a partially hydrolyzed polyacrylonitrile. It has a multiblock copolymer (MBC) structure comprising hard crystal7_ine nitrile blocks, which provide the hydrogel with good mechanical properties, and soft amorphous hydrophilic blocks to provide the hydrogel with good TM
water binding capability. The methods of preparing HYPAN
hydrogels of different water contents and mechanical properties have been disclosed in the U.S. Patents 4,337,327;
4,370,451; 4,331,783; 4,369,294; 4,420,589; 4,379,874; and 4,631,188. The pre-nuclear forms of this material, for use in this invention, can be prepared bar melt processing using solvents such as DMF and DMSO, as melting aids or by solution processing.
A preferred hydrogel for use in the practice of this invention is highly hydrolyzed crystalline polyvinyl alcohol) (PVA). The amount of hydrolyzation may be between 95 and 100 percent depending on the desired 13WC which will be from about 60% to about 90%. Generally, the final hydrogel water content increases with decreasing hydroly:aation of the initial PVA
which results in decreased crysta:Llinity.
Partially crystalline P'JA hydrogels may be prepared, from commercially available PVA powders, by any one of the methods known to the art. Preferably, they are prepared by the method disclosed in the U.S. :Patent 4,663,358. Typically, 10-15% PVA powder is mixed with a solvent, such as water, dimethyl sulfoxide (DMSO), ethylene glycol and mixtures thereof. A preferred solvent is 15% water in DMSO. The mixture is then heated at a temperature of about 10o to about 120°C, until a viscous solution i:~ formed. The solution is then poured or injected into a tubular metal, glass or plastic mold and allowed to cool to below -10°C, preferably to about -20°C.
The solution is maintained at that temperature for several hours, preferably about 20 hours, during which time crystallization and, therefore, gelation of the PVA occurs.
The shaped gel is soaked with several portions of water which are periodically replaced, over a period of at least two days, until all the organic solvent in t:he gel has been replaced by water. The hydrated gel can then be partially or completely dehydrated for implantation. The hydrogels thus prepared have EWC's between 60-90% and compressive strengths of at least 1 MNm-2, preferably about 4 MNm-2, when subject to the same constraints as the natural nucleus in an intervertebral disc.
Completion of the solvent exchange is determined by known methods. For instance, when the solvent is DMSO its removal, from the gel, is determined as follows:
50 ~L of a 0.01 N KMn04 solution are added to 50 mL
aliquots of the water which has been separated from the gels.
The presence of DMSO, in the water, will be indicated by disappearance of the characteristic pink color of the KMn04.
When the DMSO has been completely removed the pink color will not disappear. This method has a detection limit of 0.3 ppm, for DMSO, when compared to a blank and 0.3 ppm aqueous DMSO
standard.
In general, any hydrogel that can be used for - 14a -biomedical purposes can be used a~~ long as the hydrogel exhibits an EWC from about 30 to about 90% (preferably at least about 60%, more preferably at least about 70% and preferably not more than 85%, more preferably not more than 80%) and a compressive strength oi_ at least about 1 MNm-2, preferably 4 MNm-2, when subjected to the constraints of the annulus and end plates of the disc,. A rod or tube made from these materials, in a dehydrated i=orm, i.e., as xerogels, can be prepared either by cast molding or lathe cutting. In cast molding, the liquid monomer mixture, with initiator, is poured into a mold of predetermined shapE~ and size, and cured. If desired, the casting mixture may include water, or another aqueous medium. Under those circumstances the resultant rod or tube will be partially hydrated, i.e., a hydrogel. In the case of lathe cutting, the xeroge:l can be prepared, in a similar manner to the above, in the form of a block or rod which is larger than needed to foam the prosthetic nucleus.
The xerogel is then cut to the shape and size required for implantation into the disc cavity. In both cases, the hydrogel expansion factor, due to polymer swelling upon hydration, has to be taken into account in designing the mold or in cutting the block, rod or tube. The xerogel preferably has a volume of 10-70% of the hyd:rogel at its EWC.
The prosthesis is prepared by inserting at least one xerogel rod or tube, as described above, into the disc cavity through an opening, or window in 'the annulus. The xerogel can, if desired, be partially hydrated. In the practice of this invention, as illustrated in FIGS. 1-6, a xerogel rod 60 - 14b -is inserted into cavity 11 through window 62 in the annulus 16. The insertion may be effected manually or, as shown in FIG. 3, by passage between pairs of rollers 63 & 64, rotating in opposite directions, so that the window has a cross-sectional area approximately equal or slightly greater than that of the xerogel rod. When the desired amount of hydrogel has been passed into the cavity and window, past opening 65 in the annulus, whereby the xerogel rod folds upon itself a plurality of times within the cavity 11, the tail 66 of the rod 60 is pushed into the cavity :ll. At this stage, the xerogel rod only partially fills i~he cavity 11. Body fluids which are present in, or enter, tile cavity 11 are absorbed by the hydrogel rod 60 which expands to fill the cavity 11.
These processes are shown in FIGS. 4-6 wherein the hydrogel is shown at increasing water contents, up to its EWC, and, therefore, increasing extents of expansion. FIG. 6 shows the rod at its EWC, and maximum expansion, whereby the hydrogel 10 has filled, and taken the shape o:E, the cavity 11.
The exact size of the prosthetic nucleus, at its EWC, can be varied for different :individuals. A typical size of an adult nucleus is 2 cm in the semi-minor axis, 4 cm in the semi-major axis and 1.2 cm in thickness.
The major advantages of the elongated rod or tube design is that the incision area in the annulus can be reduced and it is easier to manipulate the implants during surgery.
The surfaces of the implants can either be smooth or have transverse grooves (not shown) to increase the stability of the prostheses in the disc cavities.
- 14c -The hydrogels of the present invention have a much higher structural integrity than t:he natural nucleus, i.e., they are deformed with greater difficulty under a mechanical compressive load (shaped gel vs loose gel). That is because, unlike the loose gel of the natural nucleus, the shaped gel has shape memory due to the cross-linking or strong hydrogen bonding in the polymer matrix. However, it would still have extensive lateral bulging under high compressive load if there were no boundaries to constrain the deformation. Because use of the present invention does not involve removal of the disc annulus and/or end plates, the lateral bulging of the hydrogel nucleus will be restricted by the restoring forces of the stretched fibers. Also, due to its superior structural integrity, the hydrogel nucleus will not herniate or bulge through the previously herniated areas of the incision which was made to remove the degenerated nucleus.
Since the natural nucleus is also, primarily, a hydrogel the implanted prosthetic nucleus can easily restore all the biomechanical functions o:E the nucleus which had been removed. Unlike the prior art prosthetic discs, the hydrogel nucleus of the present invention will restore the viscoelastic behavior of the disc due to the water binding capability of the prosthetic hydrogel. .
The implantation of a prosthetic nucleus 10 can be performed in conjunction with a discectomy or chemonuclealysis. Because the properties of the prosthetic nucleus of the present invention are similar to those of the nucleus material, the hemiated nucleus can be partially or totally replaced by the hydrogel prosthetic nucleus. Due to the small size of the prosthesis it can be implanted into the disc by means of a posterior lateral approach, thereby significantly reducing the difficultjr and the risk of the operation.
The volume of a hydrogel nucleus of about 80°b EWC will be reduced by about 80°6 (to about 20% of its original volume) when dehydrated.
Consequently, the surgeon does not need to jack apart the vertebrae adjacent to a damaged disc as required by, for example, the device disclosed in United States Patent 4,772,287. The height of the dehydrated prosthetic nucleus, when inserted, is smaller than the disc space. Furthermore, the rigidity of the dehydrated prosthetic nucleus will help the surgeons to manipulate the prosthetic nucleus during the operation. After implantation, the hydrogel nucleus of the present invention swells in the body to a predetermined height which is enough to maintain the space between the vertebral body. The swelling process normally takes several hours to two days depending on the size of the prosthetic nucleus and type of hydrogel.
Example 15 g PVA powder, having a molecular weight about 78000 and about 99.796 hydrolysed (Cat. No. 15129, Polysciences Inc., Warrington, PA), was mixed with 85 mL
of a solvent comprising 15°~ water in DMSO. The mixture was heated at about 110°C
until a homogenous viscous solution formed. The solution was poured into a tubular glass mold of 30 mm length and 8 mm inner diameter. The solution was cooled to about -20°C and kept at that temperature for about 20 hours whereby the PVA
crystallized and formed a gel rod. The rod was removed from the mold and washed with water until all of the DMSO had been removed therefrom. The water content of the rod was 74°6.
The above Example, to which many changes and modifications may be made, is for illustrative purposes only and is not intended to limit the spirit and scope of the invention which is defined by the claims.
The intervertebral joint exhibits both elastic and viscous behavior. Hence, during the application of a load to the disc there will be an immediate "distortion"
or "deformation" of the disc, often referred to as "instantaneous deformation".
It has been reported that the major pathway by which water is lost, from the disc during compression, is through the cartilage end-plates. Since the water permeability of the end-plates is in the range of about 0.20 to about 0.85 x 10'" m4 N'' sec'' it is reasonable to assume that under loading, the initial volume of the disc is constant while the load is applied. Because the natural nucleus of the disc is in the form of a loose hydrogel, i.e., a hydrophilic polymeric material which is insoluble in water, it can be deformed easily, the extent of deformation of the disc being largely dependent on the extensibility of the annulus. It is generally believed that the hydrostatic behavior of the nucleus plays an important role in the normal static and dynamic load-sharing capability of the disc and the restoring force of the stretched fibers of the annulus balances the effects of the nucleus swelling pressure. Without the constraint by the annulus, annular bulging of the nucleus would increase considerably. If the load is maintained at a constant level, a gradual change in joint height, commonly referred to as "creep" will occur as a function of time. Eventually, the creep will stabilize and the joint is said to be in "equilibrium". When the load is removed the joint will gradually 'recover" to its original height before loading. The creep and relaxation rates depend on the amount of load applied, the permeability of the end-plates and the water binding capability of the nucleus hydrogel. Creep and relaxation are essential processes in pumping fluid in and out of the disc.
Degeneration of the intervertebral disc is believed to be a common cause of final pathological changes and back pain. As the intervertebral disc ages it undergoes degeneration. The changes that occur are such that, in many respects, the composition of the nucleus seems to approach that of the inner annulus.
Intervertebral disc degeneration is, at least in part, the consequence of compositional changes in the nucleus. It has been found that both the molecular weight and the amount of proteoglycans in the nucleus decrease with age, especially in degenerated discs, and the ratio of keratin sulphate to chondroitin sulphate in the nucleus increases. This increase in the ratio of keratin sulphate to chondroitin sulphate and decrease in 2~.~7~~~
proteoglycan content decreases the fixed charge density of the nucleus from about 0.28 meq/ml to about 0.18 - 0.20 meq/ml. These changes cause the nucleus to lose part of its water binding capability which decreases the maximum swelling pressure it can exert. As a result, the maximum water content drops from over about 8596, in preadolescence, to about 70-75~ in middle age. The glycosaminoglycan content of prolapsed discs has been found to be lower, and the collagen content higher, than that of normal discs of a comparable age. Discs L-4 - L-5 and L-5 - S-1 are usually the most degenerated discs.
It is known that although the nucleus only occupies about one third of the total disc area, it takes about 70~ of the total loading in a normal disc. Thus, it has been found that the compressive load on the nuclei of moderately degenerated discs is about 30°~ lower than in comparable normal discs but the compressive load on the annulus increases by 10096 in the degenerated discs. This load change is primarily caused by the structural changes in the disc as discussed above. The excess load on the annulus, of the degenerated disc, causes reduction of the disc height and excessive movement of the spinal segments. The flexibility of the disc produces excessive movement of the collagenous fibers which, in turn, injures the fiber attachments and causes delamination of the well organized fibers of the annulus ring. The delaminated annulus can be further weakened by stress on the annulus and in severe cases this stress will cause tearing of the annulus. This whole process is very similar to driving on a flat tire, where the reinforcement layer will eventually delaminate.
Because the thickness of the annulus is not uniform, with the posterior portions being thinner than the anterior portions, delamination and lesions usually occur in the posterior area first.
The spinal disc may also be displaced or damaged due to trauma or diseases.
In these cases, and in the case of disc degeneration, the nucleus may hemiate and/or protrude into the vertebral canal or intervertebral foramen, in which case it is known as a herniated or "slipped" disc. This disc may in tum press upon the spinal nerve that exits the vertebral canal through the partially obstructed foramen, causing pain or paralysis in the area of its distribution. The most frequent site of occurrence of a hemiated disc is in the lower lumbar region. A disc hemiation in this area often involves the inferior extremities by compressing the sciatic nerve.
There are basically three types of treatment currently being used for treating low back pain caused by injured or degenerated discs: conservative care, discectomy and ~1~'~G'4 fusion. Each of these treatments has its advantages and limitations. The vast majority of patients with low back pain, especially those with first time episodes of low back pain, will get better with conservative care treatment. However, it is not necessarily true that conservative care is the most efficient and economical way to solve the low back pain problem.
Discectomy usually provides excellent short term results in relieving the clinical symptoms, by removing the herniated disc material, usually the nucleus, which causes < the low back pain either by compressing the spinal nerve or by chemical irritation.
Clearly, a discectomy is not desirable from a biomechanical point of view. In a healthy disc, the nucleus takes the most compressional load and in a degenerated disc this load is primarily distributed onto the annulus ring which, as described above, causes tearing and delamination of the annulus. Removal of the nucleus in a discectomy actually causes distribution the compressive load onto the annulus ring thereby narrowing the disc spaces. It has been reported that a long-term disc height decrease might be expected to cause irreversible osteoarthritis-like changes in the facet joint.
That is why discectomy yields poor long term benefits and results in a high incidence of reherniation.
Fusion generally does a good job in eliminating symptoms and stabilizing the joint. However, because the motion of the fused segment is restricted, the range of motion of the adjoining vertebral discs is increased possibly enhancing their degenerative processes.
Because of these disadvantages, it is desirable to use a prosthetic joint device which not only is able to replace the injured or degenerated intervertebral disc, but also can mimic the physiological and the biomechanical function of the replaced disc. Such a device would restore the normal functions of the disc and prevent further degeneration of the surrounding tissue.
Description of the Prior Art Artificial discs are well known in the prior art. United States Patent 3,867,728, to Stubstad et al., relates to a device which replaces the entire disc. This device is made by laminating vertical, horizontal or axial sheets of elastic polymer.
U.S. Patent 3,875,595 to Froning relates to a collapsible plastic bladder-like prosthesis of nucleus pulposus. U.S. Patent 4,309,777, to Patil, relates to a prosthesis utilizing metal springs and cups. A spinal implant comprising a rigid solid body. having a porous coating on part of its surface is shown in Kenna's U.S. Patent 4,714,469. An intervertebral disc prosthesis consisting of a pair of rigid plugs to replace the degenerated disc is referred by Kuntz, United States Patent 4,349,921. United States Patents 4,772,287 and 4,904,260, to Ray et al., teach the use of a pair of cylindrical prosthetic intervertebral disc capsules with or without therapeutical agents. U.S. Patent 4,911,718, to Lee et al., relates to an elastomeric disc spacer comprising three different parts;
nucleus, annulus and end-plates, of different materials. At the present time, none of these inventions has become a product in the spinal care market. Bao et al., in United States Patent Nos. 5,047,055 and 5,192,326 (assigned to the assignee of this invention) describe artificial nuclei comprising hydrogels in the form of large pieces shaped to conform to the shape of the disc cavity or beads within a porous envelope, respectively. The hydroge~ls have an equilibrium water content (EWC) of at least about 30% and a compressive strength of at least about 1 meganewtons per square meter (1 MNrri Z) when subjected to the constraints of the annulus and end plates of the disc. Preferably, the compressive strength of the nucleus is about 4 MNm-Z.
The primary disadvantage of the inventions of Stubstad et al., Patil, Kenna and Lee et al. is that use of their prostheses requires complete replacement of the natural disc which involves numerous surgical difficulties. Secondly, the intervertebral disc is a complex joint, anatomically and functionally, comprising the aforementioned three component structures, each of which has its own unique structural characteristics.
Designing and fabricating such a complicated prosthesis from acceptable materials, which will mimic the function of the natural disc:, is very difficult. A
further problem is the difficulty of preventing the prosthesis from dislodging. Fourthly, even for prostheses which are only intended for replacing the nucls~us, a major obstacle has been to find a material which is similar to the natural nucleus and is also able to restore the normal function of the nucleus. Hydrophobic elastome~rs and thermoplastic polymers are not desirable for use in the prosthetic nuclei due i:o their significant inherent differences from the natural nucleus e.g.; lack of hydrophilicity, in the elastomers, and lack of flexibility in the thermoplasts.
These problems are not solved by KuntJc, who uses elastic rubber plugs, or by Froning and Ray et al., who use bladders, or capsules, respectively, which are filled with a fluid or thixotropic gel. According to the Ray and Froning patents, liquid was ~1~'~u3~
used to fill the capsules and bladders, respectively, thereby requiring that their membranes be completely sealed to prevent fluid leakage. As a consequence, those devices cannot completely restore the function of the nucleus which allows body fluid to diffuse in and out during cyclic loading thereby providing the nutrients the disc needs.
The Bao et al., prosthetic lumbar disc nuclei are made ftom hydrogels.
Hydrogels have been used in biomedical applications, such as contact lenses.
Among the advantages of hydrogels is that they are more biocompatible than hydrophobic elastomers and metals. This biocompatibility is largely due to the unique characteristics of hydrogels in that they are soft and contain water like the surrounding tissues and have relatively low frictional coeffients with respect to the surrounding tissues. The biocompatibility of hydrogels results in prosthetic nuclei which are more easily tolerated in the body. Furthermore, hydrophobic elastomeric and metallic gels will not permit diffusion of aqueous compositions, and their solutes, therethrough.
An additional advantage of some hydrogels is their good mechanical strength which permits them to withstand the load on the disc and restore the normal space between the vertebral bodies. The aforementioned nuclei of Bao et al. have high mechanical strength and are able to withstand the body loads and assist in the healing of the defective annuli.
Other advantages of the hydrogels, used in the Bao et al. nuclei, are their excellent viscoelastic properties and shape memory. Hydrogels contain a large amount of water which acts as a plasticizer. Part of the water is available as free water which has more freedom to leave the hydrogel when the hydrogel is partially dehydrated under mechanical pressure. This characteristic of the hydrogels enables them to creep, in the same way as the natural nucleus, under compression, and to withstand cyclic loading for long periods without any significant degradation or loss of their elasticity.
This is because water in the hydrogel behaves like a cushion whereby the polymeric network of a hydrogel with a high EWC is less susceptible to damage under mechanical load.
Another advantage of hydrogels is their permeability to water and water-soluble substances, such as nutrients, metabolites and the like. It is known that body fluid diffusion, under cyclic loading, is the major source of nutrients to the natural disc. If __ 2 ~~'~1~~~
_$_ the route of this nutrient diffusion is blocked, e.g., by a water-impermeable nucleus, further deterioration of the disc will ensue.
Hydrogels can be dehydrated and the resultant xerogels hydrated again without changing the properties of the hydrogels. When a hydrogel is dehydrated, its volume decreases, thereby facilitating implantation of the prosthetic nucleus into the nuclear cavity in the disc. The implanted prosthetic nucleus will then swell, in the body, by absorption of body fluid up to its EWC. . The EWC of a hydrogel depends on the compressive load applied thereto. Thus, the EWC of a specific hydrogel in an open container will differ from the EWC of the same hydrogel in a closed vessel such as an intervertabral disc. The EWC values, referred to below, are for hydrogels subjected to compressive loads under the conditions found in an intervertebral disc. The expansion factor of a dehydrated hydrogel, in turn, is dependent on its EWC. Thus, it may vary from 1.19 for a hydrogel of 38% EWC to 1.73 for a hydrogel of 80~ EWC. For an 80~
EWC hydrogel, the volume of the dehydrated prosthetic nucleus is usually about of that of the hydrated one. The ability to be dehydrated and then return to its original shape upon hydration, up to its EWC, makes it possible to implant the device posterior-laterally during surgery, thereby reducing the complexity and risk of intraspinal surgery as traditionally used. The danger of perforation of the nerve, dural sac, arteries and other organs is also reduced. In addition, the incision area on the annulus can be reduced, thereby helping to heal the annulus and prevent the reherniation of the disc.
Hydrogels are also useful for drug delivery into the disc due to their capability for controlled release of drugs. Various therapeutic agents, such as growth factors, long term analgesics and anti-inflammatory agents can attach to the prosthetic nucleus and be released in a controllable rate after implantation of the nucleus in the disc..
Furthermore, dimensional integrity can be maintained with hydrogels having a water content of up to about 90~°. This dimensional integrity, if the nucleus is properly designed, will aid in distributing the vertebral load to a larger area on the annulus ring and prevent the prosthetic nucleus from bulging and hemiating.
However, it is normally difficult to implant a fully hydrated hydrogel prosthesis in the cavity, of a disc, through the small window provided in the disc, for removing the herniated nucleus, especially in a percutaneous surgery by virtue of their bulkiness in a fully hydrated state. Therefore, such prostheses must be implanted, in the disc in relatively dehydrated states which requires long periods to achieve their EWCs due to _ g _ their low surface areas. Other hydrogels, having high surface areas, do not completely conform t:o the shape of the nuclear cavity.
It has been found that t:he hydrogel prosthetic nuclei of the present invention, and the method for their preparation, overcome the disadvantages of the prior art prosthetic nuclei.
SUMMARY OF THE INVENTION
In the following description of the invention the term "partially hydrated xerogel" refers to a hydrophilic xerogel which has absorbed water t:o an extent less than its EWC under its expected conditions of use.
The present invention relates to a hydrogel prosthetic nucleus which may be implanted in the nuclear cavity, of an intervertebral disc, as one or more xerogel rods or tubes which may be partially hydrated. The prosthetic nucleus of the invention may be brought to its EWC more rapidly than the hydrogel prostheses of the prior art due to its greater surface area and its ability to retain its shape without the support of a container such as the envelope required in the case of nuclei foamed from hydrogel beads.
The prosthetic nucleus :is prepared from one or more pieces of hydrophilic xerogel material, in the form of rods or tubes, which in their final, fully hydrated state, will essentially completely fill the nucleus cavity in the disc.
Utilizing the hydrogel material i:n the form of the rod or tube facilitates implantation which ca:n be effected with the nuclear material in a partially hydrated state.
- 9a -One advantage of the pro sthetic nuclei of the present invention is the decrease in the time for rehydration, in the body, by virtue of their high surface areas.
Other advantages of the invention are the lack of the need for forming the xerogel in the shape of the cavity or enclosing the xerogel, in the fornn of beads, in an envelope comprising a semipermeable membrane or inserting the prosthesis into the cavity in a dehydrated or nearly dehydrated state. The implant of the invention, to the contrary, may be inserted into the' disc cavity in a partially hydrated state with the concomitant advantages enumerated above.
Thus, the prosthetic nu<:leus, of the present invention, may be inserted into the cavity in its partially hydrated form since the cross-seci:ional diameter of the partially hydrated rod is typically small, e.g., between about 2 and about 10 mm, more preferably between about 4 and 8 mm.
However, if the diameter of the rod is too small it may be reextruded from the cavity upon the _ ?~.~'~~3~
-, 0-application of pressure thereto whereas a very large diameter would make implantation of the rod, through the window, difficult. Nevertheless, a.slight excess in the diameter of the rod can be tolerated since, in the hydrated form, the diameter of the rod may be reduced by stretching. Furthermore, the probability of reextrusion of the implant is reduced since the implant comprises a long rod.
After hydration of the hydrogel tube or rod to its EWC, in the disc, the expanded tube or rod will essentially fill the cavity, from which the natural nucleus had been excised, and be constrained tightly therein by the annulus and end plates. The constraining forces are the restoring force of the stretched fibers of the annulus and the external force through the end-plates which will restrict the movement of the hydrogel nucleus and prevent it from bulging and hemiating from the cavity.
Another advantage of this invention is the quick restoration of the biomechanical functions of the disc which depend on the degree of hydration of the implant.
It is an object of the invention to provide a prosthetic nucleus for a disc which functions in a manner similar to that of the natural nucleus.
It is yet another object of the invention to provide a prosthetic nucleus for a disc which is composed of a hydrogel material capable of balancing its hydrostatic pressure with external loads thereon.
It is another object of the invention to provide a prosthetic nucleus, as described above, wherein said hydrogel is implanted as a rod or hollow tube.
Another object of the invention is to provide a hydrogel prosthetic nucleus having an EWC, when subjected to the constraints of the annulus and end plates of the disc, of about 30 to about 9096, preferably about 60-8096, and a compressive strength of at least about 1 MNrri ~ under normal constraints wherein said prosthetic nucleus comprises one or more hydrogel rods or tubes. Preferably, the compressive strength of the nucleus is about 4 MNrri Z.
These and other objects and advantages of the present invention will become apparent from the following description and the accompanying drawings, which disclose a preferred embodiment of the invention. It is to be understood that the drawings are to be used for the purposes of illustration only and not as a limitation on the scope of the invention.
BRIEF DESCRIPTION OF THE DRAWINGS
In the drawings wherein similar reference characters denote similar elements throughout: the several views:
FIG. 1 is an elevationa:L view, of a vertebral disc, absent its nucleus, with its associated vertebrae.
FIG. 2 is an elevationa:L view of an intervertebral disc and associated vertebrae, of FIG. 1, from the nucleus has been removed.
FIG. 3 is an elevationa:L view, of the disc of FIG. 2 with the partially hydrated xerogf~l prosthetic nucleus of the present invention being implanted therein.
FIG. 4 is an elevationa:L view of the disc of FIG. 2 showing the prosthetic nucleus of the present invention in the partially hydrated state.
FIG. 5 is an elevationa:l view of the disc and nuclear material of FIG. 3 wherein the tail end of the hydrogel rod has been inserted into the nuclear cavity.
FIG. 6 is an elevationa:l view of the disc and nuclear material of FIG. 3 wherein the hydrogel has absorbed water, to its EWC, expanded to it;s maximum size and filled the nuclear cavity.
DESCRIPTION OF THE PREFERRED EMBODIMENT
Referring to FIGS. 1 through 3, in the preferred embodiment the hydrogel prostheti~~ nucleus of the present invention, generally denoted as 10, conforms, when hydrated to its EWC, to the general shape of 'the natural nucleus. The prosthetic nucleus is implanted i:n the disc 12 of the vertebrae 14 and is surrounded by the natural annulus 16.
Vertebral end plates 20 and 22, as shown in FIG. 1, cover the superior and inferior faces of nuc;leus 10 respectively.
Hydrogels useful in the practice of the invention include lightly cross-linked biocompatible homopolymers and copolymers of hydrophilic monomers such as 2-hydroxyalkyl acrylates and methacrylates, e.g., 2-hydroxyethyl methacrylate (HEMA); N-vinyl monomers, for exannple, N-vinyl-2-pyrrolidone (N-VP); ethylenically unsaturated acids, for example, methacrylic acid (MA) and ethylenically unsaturated bases such as 2-(diethylamino)ethyl methacrylate (DEAEMA). The copolymers may further include residues from non-hydrophilic monomers such as alkyl methacrylat:es, for example, methyl methacrylate (MMA), and the like. The cross-linking polymers are formed, by known methods, in the presence of cross-linking agents, containing at least two et~hylenically unsaturated sites, such as ethyleneglycol dimethacrylate and methylenebis(acrylamide), and inii~iators such as 2,2-azobis(isobutyronitrile), benzoyl peroxide, and the like, and radiation such as W and 'y-ray.
Methods for the preparai~ion of these polymers and copolymers is well known to the a:rt. The EWC of these TM
hydrogels can vary, e.g., from about 38% for Polymacon (poly HEMA) to about 79% for Lidofilcon~M B (a copolymer of N-VP and MMA) under ambient conditions.
Another type of hydroge:L, useful in the practice of the invention, is illustrated by 13YPANTM and polyvinyl alcohol) (PVA) hydrogels. These :hydrogels, unlike the aforementioned hydrogels, are not cross-linked. Their insolubility in aqueous media is due to their partially crystalline structures. HYPANTM is a partially hydrolyzed polyacrylonitrile. It has a multiblock copolymer (MBC) structure comprising hard crystal7_ine nitrile blocks, which provide the hydrogel with good mechanical properties, and soft amorphous hydrophilic blocks to provide the hydrogel with good TM
water binding capability. The methods of preparing HYPAN
hydrogels of different water contents and mechanical properties have been disclosed in the U.S. Patents 4,337,327;
4,370,451; 4,331,783; 4,369,294; 4,420,589; 4,379,874; and 4,631,188. The pre-nuclear forms of this material, for use in this invention, can be prepared bar melt processing using solvents such as DMF and DMSO, as melting aids or by solution processing.
A preferred hydrogel for use in the practice of this invention is highly hydrolyzed crystalline polyvinyl alcohol) (PVA). The amount of hydrolyzation may be between 95 and 100 percent depending on the desired 13WC which will be from about 60% to about 90%. Generally, the final hydrogel water content increases with decreasing hydroly:aation of the initial PVA
which results in decreased crysta:Llinity.
Partially crystalline P'JA hydrogels may be prepared, from commercially available PVA powders, by any one of the methods known to the art. Preferably, they are prepared by the method disclosed in the U.S. :Patent 4,663,358. Typically, 10-15% PVA powder is mixed with a solvent, such as water, dimethyl sulfoxide (DMSO), ethylene glycol and mixtures thereof. A preferred solvent is 15% water in DMSO. The mixture is then heated at a temperature of about 10o to about 120°C, until a viscous solution i:~ formed. The solution is then poured or injected into a tubular metal, glass or plastic mold and allowed to cool to below -10°C, preferably to about -20°C.
The solution is maintained at that temperature for several hours, preferably about 20 hours, during which time crystallization and, therefore, gelation of the PVA occurs.
The shaped gel is soaked with several portions of water which are periodically replaced, over a period of at least two days, until all the organic solvent in t:he gel has been replaced by water. The hydrated gel can then be partially or completely dehydrated for implantation. The hydrogels thus prepared have EWC's between 60-90% and compressive strengths of at least 1 MNm-2, preferably about 4 MNm-2, when subject to the same constraints as the natural nucleus in an intervertebral disc.
Completion of the solvent exchange is determined by known methods. For instance, when the solvent is DMSO its removal, from the gel, is determined as follows:
50 ~L of a 0.01 N KMn04 solution are added to 50 mL
aliquots of the water which has been separated from the gels.
The presence of DMSO, in the water, will be indicated by disappearance of the characteristic pink color of the KMn04.
When the DMSO has been completely removed the pink color will not disappear. This method has a detection limit of 0.3 ppm, for DMSO, when compared to a blank and 0.3 ppm aqueous DMSO
standard.
In general, any hydrogel that can be used for - 14a -biomedical purposes can be used a~~ long as the hydrogel exhibits an EWC from about 30 to about 90% (preferably at least about 60%, more preferably at least about 70% and preferably not more than 85%, more preferably not more than 80%) and a compressive strength oi_ at least about 1 MNm-2, preferably 4 MNm-2, when subjected to the constraints of the annulus and end plates of the disc,. A rod or tube made from these materials, in a dehydrated i=orm, i.e., as xerogels, can be prepared either by cast molding or lathe cutting. In cast molding, the liquid monomer mixture, with initiator, is poured into a mold of predetermined shapE~ and size, and cured. If desired, the casting mixture may include water, or another aqueous medium. Under those circumstances the resultant rod or tube will be partially hydrated, i.e., a hydrogel. In the case of lathe cutting, the xeroge:l can be prepared, in a similar manner to the above, in the form of a block or rod which is larger than needed to foam the prosthetic nucleus.
The xerogel is then cut to the shape and size required for implantation into the disc cavity. In both cases, the hydrogel expansion factor, due to polymer swelling upon hydration, has to be taken into account in designing the mold or in cutting the block, rod or tube. The xerogel preferably has a volume of 10-70% of the hyd:rogel at its EWC.
The prosthesis is prepared by inserting at least one xerogel rod or tube, as described above, into the disc cavity through an opening, or window in 'the annulus. The xerogel can, if desired, be partially hydrated. In the practice of this invention, as illustrated in FIGS. 1-6, a xerogel rod 60 - 14b -is inserted into cavity 11 through window 62 in the annulus 16. The insertion may be effected manually or, as shown in FIG. 3, by passage between pairs of rollers 63 & 64, rotating in opposite directions, so that the window has a cross-sectional area approximately equal or slightly greater than that of the xerogel rod. When the desired amount of hydrogel has been passed into the cavity and window, past opening 65 in the annulus, whereby the xerogel rod folds upon itself a plurality of times within the cavity 11, the tail 66 of the rod 60 is pushed into the cavity :ll. At this stage, the xerogel rod only partially fills i~he cavity 11. Body fluids which are present in, or enter, tile cavity 11 are absorbed by the hydrogel rod 60 which expands to fill the cavity 11.
These processes are shown in FIGS. 4-6 wherein the hydrogel is shown at increasing water contents, up to its EWC, and, therefore, increasing extents of expansion. FIG. 6 shows the rod at its EWC, and maximum expansion, whereby the hydrogel 10 has filled, and taken the shape o:E, the cavity 11.
The exact size of the prosthetic nucleus, at its EWC, can be varied for different :individuals. A typical size of an adult nucleus is 2 cm in the semi-minor axis, 4 cm in the semi-major axis and 1.2 cm in thickness.
The major advantages of the elongated rod or tube design is that the incision area in the annulus can be reduced and it is easier to manipulate the implants during surgery.
The surfaces of the implants can either be smooth or have transverse grooves (not shown) to increase the stability of the prostheses in the disc cavities.
- 14c -The hydrogels of the present invention have a much higher structural integrity than t:he natural nucleus, i.e., they are deformed with greater difficulty under a mechanical compressive load (shaped gel vs loose gel). That is because, unlike the loose gel of the natural nucleus, the shaped gel has shape memory due to the cross-linking or strong hydrogen bonding in the polymer matrix. However, it would still have extensive lateral bulging under high compressive load if there were no boundaries to constrain the deformation. Because use of the present invention does not involve removal of the disc annulus and/or end plates, the lateral bulging of the hydrogel nucleus will be restricted by the restoring forces of the stretched fibers. Also, due to its superior structural integrity, the hydrogel nucleus will not herniate or bulge through the previously herniated areas of the incision which was made to remove the degenerated nucleus.
Since the natural nucleus is also, primarily, a hydrogel the implanted prosthetic nucleus can easily restore all the biomechanical functions o:E the nucleus which had been removed. Unlike the prior art prosthetic discs, the hydrogel nucleus of the present invention will restore the viscoelastic behavior of the disc due to the water binding capability of the prosthetic hydrogel. .
The implantation of a prosthetic nucleus 10 can be performed in conjunction with a discectomy or chemonuclealysis. Because the properties of the prosthetic nucleus of the present invention are similar to those of the nucleus material, the hemiated nucleus can be partially or totally replaced by the hydrogel prosthetic nucleus. Due to the small size of the prosthesis it can be implanted into the disc by means of a posterior lateral approach, thereby significantly reducing the difficultjr and the risk of the operation.
The volume of a hydrogel nucleus of about 80°b EWC will be reduced by about 80°6 (to about 20% of its original volume) when dehydrated.
Consequently, the surgeon does not need to jack apart the vertebrae adjacent to a damaged disc as required by, for example, the device disclosed in United States Patent 4,772,287. The height of the dehydrated prosthetic nucleus, when inserted, is smaller than the disc space. Furthermore, the rigidity of the dehydrated prosthetic nucleus will help the surgeons to manipulate the prosthetic nucleus during the operation. After implantation, the hydrogel nucleus of the present invention swells in the body to a predetermined height which is enough to maintain the space between the vertebral body. The swelling process normally takes several hours to two days depending on the size of the prosthetic nucleus and type of hydrogel.
Example 15 g PVA powder, having a molecular weight about 78000 and about 99.796 hydrolysed (Cat. No. 15129, Polysciences Inc., Warrington, PA), was mixed with 85 mL
of a solvent comprising 15°~ water in DMSO. The mixture was heated at about 110°C
until a homogenous viscous solution formed. The solution was poured into a tubular glass mold of 30 mm length and 8 mm inner diameter. The solution was cooled to about -20°C and kept at that temperature for about 20 hours whereby the PVA
crystallized and formed a gel rod. The rod was removed from the mold and washed with water until all of the DMSO had been removed therefrom. The water content of the rod was 74°6.
The above Example, to which many changes and modifications may be made, is for illustrative purposes only and is not intended to limit the spirit and scope of the invention which is defined by the claims.
Claims (21)
1. A prosthetic nucleus implant comprising before implantation at least one elongate, partially hydrated hydrogel member having a cross-sectional diameter of between about 2 mm and about 10 mm, wherein the member is sized and configured (a) to fold upon itself a plurality of times within a nucleus cavity upon insertion therein to only partially fill the cavity, and (b) subsequently upon an increase in hydration, to essentially fill and conform to the shape of the cavity.
2. The prosthetic nucleus of claim 1, which is sized and configured upon an increase in hydration to its equilibrium water content to essentially fill and conform to the shape of the cavity.
3. The prosthetic nucleus of claim 2, wherein the equilibrium water content of the hydrogel is from about 30 to about 90%.
4. The prosthetic nucleus of claim 2, wherein the equilibrium water content of the hydrogel is from about 60 to about 80%.
5. The prosthetic nucleus of any one of claims 2 to 4, wherein the partially hydrated member has a volume of 10-70%
of that of the hydrogel at its equilibrium water content.
of that of the hydrogel at its equilibrium water content.
6. The prosthetic nucleus of any one of claims 1 to 5, wherein the diameter of the partially hydrated member is from about 4 to about 8 mm.
7. The prosthetic nucleus of any one of claims 1 to 6, consisting of only a single member.
8. The prosthetic nucleus of any one of claims 1 to 6, consisting of a plurality of members.
9. The prosthetic nucleus of any one of claims 1 to 7, wherein the hydrogel is made of polyvinyl alcohol.
10. The prosthetic nucleus of any one of claims 1 to 7, wherein the hydrogel is prepared by the homo- or co-polymerization of hydrophilic monomers selected from the group consisting of N-vinyl monomers, hydroxyalkyl acrylates and methacrylates, ethylenically unsaturated acids and bases and their salts and mixtures thereof, in the presence of a cross-linking monomer containing at least two ethylenically unsaturated sites.
11. The prosthetic nucleus of any one of claims 1 to 7, wherein the hydrogel is made of partially hydrolyzed polyacrylonitrile.
12. The prosthetic nucleus of claim 10, wherein the cross-linking monomer is ethyleneglycol dimethacrylate.
13. The prosthetic nucleus of claim 10, wherein the hydroxyalkyl methacrylate is 2-hydroxyethyl methacrylate; the N-vinyl monomer is N-vinyl-2-pyrrolidone; the ethylenically unsaturated acid is methacrylic acid; the ethylenically unsaturated base is 2-(diethylamino)ethyl methacrylate; and the cross-linking monomer is ethyleneglycol dimethacrylate.
14. The prosthetic nucleus of claim 10, wherein the copolymer is formed by copolymerizing the hydrophilic monomer with at least one non-hydrophilic monomer.
15. The prosthetic nucleus of claim 14, wherein the non-hydrophilic monomer is an alkyl methacrylate.
16. The prosthetic nucleus of any one of claims 1 to 15, wherein the hydrogel has a compressive strength of at least 1 MNm-2 wherein subjected to constraints of an annulus and end plates of a disc.
17. The prosthetic nucleus of claim 16, wherein the hydrogel has a compressive strength of at least 4 MNm-2.
18. The prosthetic nucleus of claim 1, wherein the member is made of a homogeneous hydrogel.
19. A prosthetic nucleus implant to be implanted into a cavity of an intervertebral disc having an annulus and vertebral end plates, the cavity being in fluid connection with outer surroundings of the disc through a window in the annulus and formed by removing natural nucleus from the intervertebral disc, which implant comprises:
an elongate xerogel rod having a cross-section diameter of between 2 mm and 10 mm, an equilibrium water content (EWC) when subjected to constraints of the annulus and the end plates of 30 to 90% and a compressive strength of at least 1 NMm-2, wherein the xerogel rod is so sized and configured (a) to fold upon itself a plurality of times within the cavity upon insertion therein to only partially fill the cavity and (b) subsequently upon absorbing a body fluid, to expand to essentially fill and conform to the cavity.
an elongate xerogel rod having a cross-section diameter of between 2 mm and 10 mm, an equilibrium water content (EWC) when subjected to constraints of the annulus and the end plates of 30 to 90% and a compressive strength of at least 1 NMm-2, wherein the xerogel rod is so sized and configured (a) to fold upon itself a plurality of times within the cavity upon insertion therein to only partially fill the cavity and (b) subsequently upon absorbing a body fluid, to expand to essentially fill and conform to the cavity.
20. The prosthetic implant according to claim 19, wherein the elongate xerogel rod has a volume of 10 to 70% of that at its equilibrium water content.
21. The prosthetic implant according to claim 19 or 20, wherein the elongate rod is made of xerogel of a biocompatible cross-linked homopolymer or copolymer of at least one hydrophilic monomer selected from the group consisting of 2-hydroxyalkyl acrylates or methacrylates, N-vinyl monomers, ethylenically unsaturated acids, ethylenically unsaturated bases alone or in combination with at least one non-hydrophilic monomer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30329794A | 1994-09-08 | 1994-09-08 | |
US08/303,297 | 1994-09-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2157634A1 CA2157634A1 (en) | 1996-03-09 |
CA2157634C true CA2157634C (en) | 2000-10-03 |
Family
ID=23171408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002157634A Expired - Fee Related CA2157634C (en) | 1994-09-08 | 1995-09-06 | Hydrogel intervertebral disc nucleus |
Country Status (7)
Country | Link |
---|---|
US (2) | US5976186A (en) |
EP (1) | EP0700671B1 (en) |
JP (1) | JP2735517B2 (en) |
AT (1) | ATE203885T1 (en) |
AU (1) | AU686855B2 (en) |
CA (1) | CA2157634C (en) |
DE (1) | DE69522060T2 (en) |
Families Citing this family (465)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998020939A2 (en) | 1996-11-15 | 1998-05-22 | Advanced Bio Surfaces, Inc. | Biomaterial system for in situ tissue repair |
ATE349190T1 (en) * | 1995-11-08 | 2007-01-15 | Zimmer Gmbh | DEVICE FOR INSERTING AN IMPLANT, IN PARTICULAR AN INTERVERBAL PROSTHESIS |
US7101375B2 (en) * | 1997-01-02 | 2006-09-05 | St. Francis Medical Technologies, Inc. | Spine distraction implant |
US6712819B2 (en) | 1998-10-20 | 2004-03-30 | St. Francis Medical Technologies, Inc. | Mating insertion instruments for spinal implants and methods of use |
US20080039859A1 (en) | 1997-01-02 | 2008-02-14 | Zucherman James F | Spine distraction implant and method |
US5836948A (en) | 1997-01-02 | 1998-11-17 | Saint Francis Medical Technologies, Llc | Spine distraction implant and method |
US6514256B2 (en) | 1997-01-02 | 2003-02-04 | St. Francis Medical Technologies, Inc. | Spine distraction implant and method |
US6068630A (en) | 1997-01-02 | 2000-05-30 | St. Francis Medical Technologies, Inc. | Spine distraction implant |
US20080086212A1 (en) | 1997-01-02 | 2008-04-10 | St. Francis Medical Technologies, Inc. | Spine distraction implant |
US7959652B2 (en) | 2005-04-18 | 2011-06-14 | Kyphon Sarl | Interspinous process implant having deployable wings and method of implantation |
US6902566B2 (en) | 1997-01-02 | 2005-06-07 | St. Francis Medical Technologies, Inc. | Spinal implants, insertion instruments, and methods of use |
US6796983B1 (en) | 1997-01-02 | 2004-09-28 | St. Francis Medical Technologies, Inc. | Spine distraction implant and method |
US7306628B2 (en) | 2002-10-29 | 2007-12-11 | St. Francis Medical Technologies | Interspinous process apparatus and method with a selectably expandable spacer |
US7201751B2 (en) | 1997-01-02 | 2007-04-10 | St. Francis Medical Technologies, Inc. | Supplemental spine fixation device |
US8128661B2 (en) | 1997-01-02 | 2012-03-06 | Kyphon Sarl | Interspinous process distraction system and method with positionable wing and method |
US6695842B2 (en) | 1997-10-27 | 2004-02-24 | St. Francis Medical Technologies, Inc. | Interspinous process distraction system and method with positionable wing and method |
WO1998030141A2 (en) | 1997-01-09 | 1998-07-16 | Cohesion Technologies, Inc. | Devices for tissue repair and methods for preparation and use thereof |
US6017366A (en) * | 1997-04-18 | 2000-01-25 | W. L. Gore & Associates, Inc. | Resorbable interposition arthroplasty implant |
US6645138B2 (en) | 1997-09-12 | 2003-11-11 | Uromedica, Inc. | Adjustable implantable genitourinary device |
US7364540B1 (en) | 1997-06-12 | 2008-04-29 | Uromedica, Inc. | Implantable device and method for adjustably restricting a body lumen |
US6419624B1 (en) | 1999-10-11 | 2002-07-16 | Uromedica, Inc. | Apparatus and method for inserting an adjustable implantable genitourinary device |
US6045498A (en) * | 1997-06-12 | 2000-04-04 | Uromedica, Inc. | Method for adjustably restricting a body lumen |
US6579224B1 (en) | 1999-10-11 | 2003-06-17 | Uromedica, Inc. | Apparatus and method for inserting an adjustable implantable genitourinary device |
GB9714580D0 (en) * | 1997-07-10 | 1997-09-17 | Wardlaw Douglas | Prosthetic intervertebral disc nucleus |
DE69714035T2 (en) | 1997-08-14 | 2003-03-06 | Sulzer Innotec Ag | Composition and device for repairing cartilage tissue in vivo consisting of nanocapsules with osteoinductive and / or chondroinductive factors |
CA2307888C (en) | 1997-10-27 | 2007-09-18 | Saint Francis Medical Technologies, Inc. | Spine distraction implant |
US5932552A (en) | 1997-11-26 | 1999-08-03 | Keraplast Technologies Ltd. | Keratin-based hydrogel for biomedical applications and method of production |
JP2002507437A (en) * | 1998-02-27 | 2002-03-12 | バイオエラスチックス・リサーチ・リミテッド | Injectable implant for tissue augmentation and recovery |
US6224630B1 (en) * | 1998-05-29 | 2001-05-01 | Advanced Bio Surfaces, Inc. | Implantable tissue repair device |
US6652534B2 (en) | 1998-10-20 | 2003-11-25 | St. Francis Medical Technologies, Inc. | Apparatus and method for determining implant size |
US6652527B2 (en) | 1998-10-20 | 2003-11-25 | St. Francis Medical Technologies, Inc. | Supplemental spine fixation device and method |
US7029473B2 (en) | 1998-10-20 | 2006-04-18 | St. Francis Medical Technologies, Inc. | Deflectable spacer for use as an interspinous process implant and method |
US7189234B2 (en) | 1998-10-20 | 2007-03-13 | St. Francis Medical Technologies, Inc. | Interspinous process implant sizer and distractor with a split head and size indicator and method |
US6146422A (en) * | 1999-01-25 | 2000-11-14 | Lawson; Kevin Jon | Prosthetic nucleus replacement for surgical reconstruction of intervertebral discs and treatment method |
AU2999900A (en) | 1999-02-18 | 2000-09-04 | Ken Y. Hsu | Hair used as a biologic disk, replacement, and/or structure and method |
CA2594492A1 (en) * | 1999-03-07 | 2000-09-14 | Active Implants Corporation | Method and apparatus for computerized surgery |
AU4684500A (en) | 1999-04-30 | 2000-11-17 | Uromedica, Inc. | Method and apparatus for adjustable sling for treatment of urinary stress incontinence |
US20070038231A1 (en) | 1999-05-28 | 2007-02-15 | Ferree Bret A | Methods and apparatus for treating disc herniation and preventing the extrusion of interbody bone graft |
US7273497B2 (en) | 1999-05-28 | 2007-09-25 | Anova Corp. | Methods for treating a defect in the annulus fibrosis |
US20060247665A1 (en) | 1999-05-28 | 2006-11-02 | Ferree Bret A | Methods and apparatus for treating disc herniation and preventing the extrusion of interbody bone graft |
US6245107B1 (en) | 1999-05-28 | 2001-06-12 | Bret A. Ferree | Methods and apparatus for treating disc herniation |
US6419704B1 (en) * | 1999-10-08 | 2002-07-16 | Bret Ferree | Artificial intervertebral disc replacement methods and apparatus |
US6520996B1 (en) | 1999-06-04 | 2003-02-18 | Depuy Acromed, Incorporated | Orthopedic implant |
WO2001001895A1 (en) * | 1999-07-02 | 2001-01-11 | Petrus Besselink | Reinforced expandable cage |
US6755863B2 (en) * | 1999-10-08 | 2004-06-29 | Bret A. Ferree | Rotator cuff repair using engineered tissues |
US7435260B2 (en) * | 1999-08-13 | 2008-10-14 | Ferree Bret A | Use of morphogenetic proteins to treat human disc disease |
US7201776B2 (en) * | 1999-10-08 | 2007-04-10 | Ferree Bret A | Artificial intervertebral disc replacements with endplates |
US6936072B2 (en) | 1999-08-18 | 2005-08-30 | Intrinsic Therapeutics, Inc. | Encapsulated intervertebral disc prosthesis and methods of manufacture |
US8323341B2 (en) | 2007-09-07 | 2012-12-04 | Intrinsic Therapeutics, Inc. | Impaction grafting for vertebral fusion |
JP4247519B2 (en) | 1999-08-18 | 2009-04-02 | イントリンジック セラピューティックス インコーポレイテッド | Apparatus and method for nucleus augmentation and retention |
US7094258B2 (en) | 1999-08-18 | 2006-08-22 | Intrinsic Therapeutics, Inc. | Methods of reinforcing an annulus fibrosis |
US7998213B2 (en) | 1999-08-18 | 2011-08-16 | Intrinsic Therapeutics, Inc. | Intervertebral disc herniation repair |
US7972337B2 (en) | 2005-12-28 | 2011-07-05 | Intrinsic Therapeutics, Inc. | Devices and methods for bone anchoring |
US7507243B2 (en) * | 1999-08-18 | 2009-03-24 | Gregory Lambrecht | Devices and method for augmenting a vertebral disc |
EP1624832A4 (en) | 1999-08-18 | 2008-12-24 | Intrinsic Therapeutics Inc | Devices and method for augmenting a vertebral disc nucleus |
US7553329B2 (en) | 1999-08-18 | 2009-06-30 | Intrinsic Therapeutics, Inc. | Stabilized intervertebral disc barrier |
US7717961B2 (en) | 1999-08-18 | 2010-05-18 | Intrinsic Therapeutics, Inc. | Apparatus delivery in an intervertebral disc |
US6821276B2 (en) | 1999-08-18 | 2004-11-23 | Intrinsic Therapeutics, Inc. | Intervertebral diagnostic and manipulation device |
US6425919B1 (en) | 1999-08-18 | 2002-07-30 | Intrinsic Orthopedics, Inc. | Devices and methods of vertebral disc augmentation |
US6783546B2 (en) | 1999-09-13 | 2004-08-31 | Keraplast Technologies, Ltd. | Implantable prosthetic or tissue expanding device |
US6264695B1 (en) * | 1999-09-30 | 2001-07-24 | Replication Medical, Inc. | Spinal nucleus implant |
US20040172019A1 (en) * | 1999-10-08 | 2004-09-02 | Ferree Bret A. | Reinforcers for artificial disc replacement methods and apparatus |
US20030026788A1 (en) * | 1999-10-08 | 2003-02-06 | Ferree Bret A. | Use of extracellular matrix tissue to preserve cultured cell phenotype |
US6432107B1 (en) * | 2000-01-15 | 2002-08-13 | Bret A. Ferree | Enhanced surface area spinal fusion devices |
US7060100B2 (en) * | 1999-10-08 | 2006-06-13 | Ferree Bret A | Artificial disc and joint replacements with modular cushioning components |
US20030040796A1 (en) * | 1999-10-08 | 2003-02-27 | Ferree Bret A. | Devices used to treat disc herniation and attachment mechanisms therefore |
US6645247B2 (en) * | 1999-10-08 | 2003-11-11 | Bret A. Ferree | Supplementing engineered annulus tissues with autograft of allograft tendons |
US6875235B2 (en) * | 1999-10-08 | 2005-04-05 | Bret A. Ferree | Prosthetic joints with contained compressible resilient members |
US6648920B2 (en) * | 1999-10-08 | 2003-11-18 | Bret A. Ferree | Natural and synthetic supplements to engineered annulus and disc tissues |
US7201774B2 (en) * | 1999-10-08 | 2007-04-10 | Ferree Bret A | Artificial intervertebral disc replacements incorporating reinforced wall sections |
US8679180B2 (en) * | 1999-10-08 | 2014-03-25 | Anova Corporation | Devices used to treat disc herniation and attachment mechanisms therefore |
US7052516B2 (en) | 1999-10-20 | 2006-05-30 | Anulex Technologies, Inc. | Spinal disc annulus reconstruction method and deformable spinal disc annulus stent |
US7615076B2 (en) | 1999-10-20 | 2009-11-10 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US8632590B2 (en) | 1999-10-20 | 2014-01-21 | Anulex Technologies, Inc. | Apparatus and methods for the treatment of the intervertebral disc |
US8128698B2 (en) | 1999-10-20 | 2012-03-06 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US7951201B2 (en) | 1999-10-20 | 2011-05-31 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US7004970B2 (en) * | 1999-10-20 | 2006-02-28 | Anulex Technologies, Inc. | Methods and devices for spinal disc annulus reconstruction and repair |
US7935147B2 (en) | 1999-10-20 | 2011-05-03 | Anulex Technologies, Inc. | Method and apparatus for enhanced delivery of treatment device to the intervertebral disc annulus |
US6592625B2 (en) * | 1999-10-20 | 2003-07-15 | Anulex Technologies, Inc. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
IT1311576B1 (en) * | 1999-10-25 | 2002-03-13 | Ghimas Spa | INVASIVE MEDICAL DEVICE, IN PARTICULAR FOR GUIDED TISSUE REGENERATION. |
ATE257397T1 (en) * | 1999-10-29 | 2004-01-15 | Univ Drexel | BINDING HYDROGELS TO REPLACE THE NUCLEUS PULPOSUS |
US7214245B1 (en) * | 1999-10-29 | 2007-05-08 | Drexel University | Associating hydrogels for nucleus pulposus replacement in intervertebral discs |
CA2392721C (en) * | 1999-12-06 | 2009-01-20 | Sdgi Holdings, Inc. | Intervertebral disc treatment devices and methods |
US6610079B1 (en) | 1999-12-14 | 2003-08-26 | Linvatec Corporation | Fixation system and method |
US7547324B2 (en) * | 2000-02-16 | 2009-06-16 | Trans1, Inc. | Spinal mobility preservation apparatus having an expandable membrane |
US7727263B2 (en) | 2000-02-16 | 2010-06-01 | Trans1, Inc. | Articulating spinal implant |
US6899716B2 (en) | 2000-02-16 | 2005-05-31 | Trans1, Inc. | Method and apparatus for spinal augmentation |
US6689125B1 (en) | 2000-04-04 | 2004-02-10 | Spinalabs, Llc | Devices and methods for the treatment of spinal disorders |
US6579291B1 (en) | 2000-10-10 | 2003-06-17 | Spinalabs, Llc | Devices and methods for the treatment of spinal disorders |
US6805695B2 (en) | 2000-04-04 | 2004-10-19 | Spinalabs, Llc | Devices and methods for annular repair of intervertebral discs |
US6402750B1 (en) | 2000-04-04 | 2002-06-11 | Spinlabs, Llc | Devices and methods for the treatment of spinal disorders |
US6723335B1 (en) | 2000-04-07 | 2004-04-20 | Jeffrey William Moehlenbruck | Methods and compositions for treating intervertebral disc degeneration |
ITVI20000025U1 (en) * | 2000-04-07 | 2001-10-07 | Tecres Spa | TEMPORARY SPACER DEVICE FOR SURGICAL TREATMENT OF THE KNEE |
AU2001261969A1 (en) * | 2000-05-25 | 2001-12-03 | Neurortho Implants Design, Llc | Inter-vertebral disc prosthesis for rachis for an anterior surgery thereof |
US20030229348A1 (en) * | 2000-05-25 | 2003-12-11 | Sevrain Lionel C. | Auxiliary vertebrae connecting device |
AU2001261979B2 (en) * | 2000-05-25 | 2005-09-01 | Orthoplex, Llc | Anchoring system for fixing objects to bones |
DE50106944D1 (en) * | 2000-05-26 | 2005-09-08 | Zimmer Gmbh Winterthur | Intervertebral disc replacement for the nucleus of an intervertebral disc |
US6533817B1 (en) | 2000-06-05 | 2003-03-18 | Raymedica, Inc. | Packaged, partially hydrated prosthetic disc nucleus |
US7144414B2 (en) | 2000-06-27 | 2006-12-05 | Smith & Nephew, Inc. | Surgical procedures and instruments |
US20050154463A1 (en) * | 2000-08-30 | 2005-07-14 | Trieu Hal H. | Spinal nucleus replacement implants and methods |
US7204851B2 (en) | 2000-08-30 | 2007-04-17 | Sdgi Holdings, Inc. | Method and apparatus for delivering an intervertebral disc implant |
US6620196B1 (en) | 2000-08-30 | 2003-09-16 | Sdgi Holdings, Inc. | Intervertebral disc nucleus implants and methods |
US20020026244A1 (en) * | 2000-08-30 | 2002-02-28 | Trieu Hai H. | Intervertebral disc nucleus implants and methods |
US7503936B2 (en) | 2000-08-30 | 2009-03-17 | Warsaw Orthopedic, Inc. | Methods for forming and retaining intervertebral disc implants |
AU2001293581A1 (en) * | 2000-09-26 | 2002-04-08 | Neurortho Implants Design, Llc | Inter-vertebral disc prosthesis for lumbar rachis through posterior surgery thereof |
US6733531B1 (en) | 2000-10-20 | 2004-05-11 | Sdgi Holdings, Inc. | Anchoring devices and implants for intervertebral disc augmentation |
US6613089B1 (en) * | 2000-10-25 | 2003-09-02 | Sdgi Holdings, Inc. | Laterally expanding intervertebral fusion device |
CA2426932A1 (en) | 2000-10-25 | 2002-06-20 | Sdgi Holdings, Inc. | Vertically expanding intervertebral body fusion device |
US6692528B2 (en) * | 2000-11-09 | 2004-02-17 | The Polymer Technology Group Incorporated | Devices that change size/shape via osmotic pressure |
US6623509B2 (en) | 2000-12-14 | 2003-09-23 | Core Medical, Inc. | Apparatus and methods for sealing vascular punctures |
US6890343B2 (en) | 2000-12-14 | 2005-05-10 | Ensure Medical, Inc. | Plug with detachable guidewire element and methods for use |
US6896692B2 (en) | 2000-12-14 | 2005-05-24 | Ensure Medical, Inc. | Plug with collet and apparatus and method for delivering such plugs |
US8083768B2 (en) | 2000-12-14 | 2011-12-27 | Ensure Medical, Inc. | Vascular plug having composite construction |
US6846319B2 (en) | 2000-12-14 | 2005-01-25 | Core Medical, Inc. | Devices for sealing openings through tissue and apparatus and methods for delivering them |
US6743257B2 (en) * | 2000-12-19 | 2004-06-01 | Cortek, Inc. | Dynamic implanted intervertebral spacer |
US20060089721A1 (en) * | 2001-01-17 | 2006-04-27 | Muhanna Nabil L | Intervertebral disc prosthesis and methods of implantation |
CA2438033A1 (en) * | 2001-02-14 | 2002-08-22 | Osteotech, Inc. | Implant derived from bone |
US6673113B2 (en) | 2001-10-18 | 2004-01-06 | Spinecore, Inc. | Intervertebral spacer device having arch shaped spring elements |
US7169182B2 (en) * | 2001-07-16 | 2007-01-30 | Spinecore, Inc. | Implanting an artificial intervertebral disc |
US20020147496A1 (en) * | 2001-04-06 | 2002-10-10 | Integrated Vascular Systems, Inc. | Apparatus for treating spinal discs |
US6582433B2 (en) | 2001-04-09 | 2003-06-24 | St. Francis Medical Technologies, Inc. | Spine fixation device and method |
US6632235B2 (en) | 2001-04-19 | 2003-10-14 | Synthes (U.S.A.) | Inflatable device and method for reducing fractures in bone and in treating the spine |
US20030078579A1 (en) * | 2001-04-19 | 2003-04-24 | Ferree Bret A. | Annular repair devices and methods |
EP1399100A1 (en) * | 2001-06-27 | 2004-03-24 | Mathys Medizinaltechnik AG | Intervertebral disk prosthesis |
US7156877B2 (en) | 2001-06-29 | 2007-01-02 | The Regents Of The University Of California | Biodegradable/bioactive nucleus pulposus implant and method for treating degenerated intervertebral discs |
US20090234457A1 (en) * | 2001-06-29 | 2009-09-17 | The Regents Of The University Of California | Systems, devices and methods for treatment of intervertebral disorders |
US6926728B2 (en) * | 2001-07-18 | 2005-08-09 | St. Francis Medical Technologies, Inc. | Curved dilator and method |
US7713302B2 (en) | 2001-10-01 | 2010-05-11 | Spinecore, Inc. | Intervertebral spacer device utilizing a spirally slotted belleville washer having radially spaced concentric grooves |
US7771477B2 (en) | 2001-10-01 | 2010-08-10 | Spinecore, Inc. | Intervertebral spacer device utilizing a belleville washer having radially spaced concentric grooves |
JP4394441B2 (en) * | 2001-10-02 | 2010-01-06 | レックス メディカル リミテッド パートナーシップ | Spinal implant |
US6783721B2 (en) * | 2001-10-30 | 2004-08-31 | Howmedica Osteonics Corp. | Method of making an ion treated hydrogel |
MXPA04005707A (en) * | 2001-12-10 | 2005-06-20 | Colbar Lifescience Ltd D | Methods, devices, and preparations for intervertebral disc treatment. |
US6736850B2 (en) * | 2001-12-28 | 2004-05-18 | Spinal Concepts, Inc. | Vertebral pseudo arthrosis device and method |
HUP0500171A2 (en) * | 2002-04-04 | 2005-05-30 | Mathys Medizinaltechnik Ag | Intervertebral prosthesis or nucleus replacement prosthesis |
US20030195630A1 (en) * | 2002-04-10 | 2003-10-16 | Ferree Bret A. | Disc augmentation using materials that expand in situ |
US8038713B2 (en) | 2002-04-23 | 2011-10-18 | Spinecore, Inc. | Two-component artificial disc replacements |
US20030195631A1 (en) * | 2002-04-12 | 2003-10-16 | Ferree Bret A. | Shape-memory spacers for artificial disc replacements |
US20080027548A9 (en) | 2002-04-12 | 2008-01-31 | Ferree Bret A | Spacerless artificial disc replacements |
US7223289B2 (en) * | 2002-04-16 | 2007-05-29 | Warsaw Orthopedic, Inc. | Annulus repair systems and techniques |
US8388684B2 (en) | 2002-05-23 | 2013-03-05 | Pioneer Signal Technology, Inc. | Artificial disc device |
US7001433B2 (en) | 2002-05-23 | 2006-02-21 | Pioneer Laboratories, Inc. | Artificial intervertebral disc device |
US20040049283A1 (en) * | 2002-06-04 | 2004-03-11 | Tushar Patel | Medical implant and method of reducing back pain |
US7622562B2 (en) | 2002-06-26 | 2009-11-24 | Zimmer Orthobiologics, Inc. | Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue |
US6793678B2 (en) | 2002-06-27 | 2004-09-21 | Depuy Acromed, Inc. | Prosthetic intervertebral motion disc having dampening |
US7745532B2 (en) * | 2002-08-02 | 2010-06-29 | Cambridge Polymer Group, Inc. | Systems and methods for controlling and forming polymer gels |
US7485670B2 (en) * | 2002-08-02 | 2009-02-03 | Cambridge Polymer Group, Inc. | Systems and methods for controlling and forming polymer gels |
CA2496804A1 (en) * | 2002-08-27 | 2004-03-11 | Sdgi Holdings, Inc. | Systems and methods for intravertebral reduction |
FR2844179B1 (en) | 2002-09-10 | 2004-12-03 | Jean Taylor | POSTERIOR VERTEBRAL SUPPORT KIT |
US20040054413A1 (en) * | 2002-09-16 | 2004-03-18 | Howmedica Osteonics Corp. | Radiovisible hydrogel intervertebral disc nucleus |
US20040054414A1 (en) | 2002-09-18 | 2004-03-18 | Trieu Hai H. | Collagen-based materials and methods for augmenting intervertebral discs |
US7744651B2 (en) | 2002-09-18 | 2010-06-29 | Warsaw Orthopedic, Inc | Compositions and methods for treating intervertebral discs with collagen-based materials |
JP2006504452A (en) * | 2002-09-18 | 2006-02-09 | エスディージーアイ・ホールディングス・インコーポレーテッド | Intervertebral disc enhancement material based on collagen and enhancement method |
EP1585457B1 (en) | 2002-09-24 | 2010-03-31 | Bogomir Gorensek | Stabilizing device for intervertebral disc, and methods thereof |
US8679179B2 (en) * | 2002-10-03 | 2014-03-25 | Anova Corp. | Annular repair devices and methods |
US7749252B2 (en) | 2005-03-21 | 2010-07-06 | Kyphon Sarl | Interspinous process implant having deployable wing and method of implantation |
US7083649B2 (en) * | 2002-10-29 | 2006-08-01 | St. Francis Medical Technologies, Inc. | Artificial vertebral disk replacement implant with translating pivot point |
US8048117B2 (en) | 2003-05-22 | 2011-11-01 | Kyphon Sarl | Interspinous process implant and method of implantation |
US20080021468A1 (en) | 2002-10-29 | 2008-01-24 | Zucherman James F | Interspinous process implants and methods of use |
US8147548B2 (en) | 2005-03-21 | 2012-04-03 | Kyphon Sarl | Interspinous process implant having a thread-shaped wing and method of implantation |
US7833246B2 (en) | 2002-10-29 | 2010-11-16 | Kyphon SÀRL | Interspinous process and sacrum implant and method |
US8070778B2 (en) | 2003-05-22 | 2011-12-06 | Kyphon Sarl | Interspinous process implant with slide-in distraction piece and method of implantation |
US7549999B2 (en) | 2003-05-22 | 2009-06-23 | Kyphon Sarl | Interspinous process distraction implant and method of implantation |
US7909853B2 (en) | 2004-09-23 | 2011-03-22 | Kyphon Sarl | Interspinous process implant including a binder and method of implantation |
US20060064165A1 (en) * | 2004-09-23 | 2006-03-23 | St. Francis Medical Technologies, Inc. | Interspinous process implant including a binder and method of implantation |
US20040133278A1 (en) * | 2002-10-31 | 2004-07-08 | Marino James F. | Spinal disc implant |
GB0226280D0 (en) * | 2002-11-11 | 2002-12-18 | D H Res & Rheological Services | Improvements to intervertebral disc prosthesis |
CN100394989C (en) | 2002-11-15 | 2008-06-18 | 华沙整形外科股份有限公司 | Collagen-based materials and methods for augmenting intervertebral discs |
US6974479B2 (en) * | 2002-12-10 | 2005-12-13 | Sdgi Holdings, Inc. | System and method for blocking and/or retaining a prosthetic spinal implant |
US20040210310A1 (en) * | 2002-12-10 | 2004-10-21 | Trieu Hai H. | Implant system and method for intervertebral disc augmentation |
US7101398B2 (en) * | 2002-12-31 | 2006-09-05 | Depuy Acromed, Inc. | Prosthetic facet joint ligament |
WO2004064673A2 (en) * | 2003-01-17 | 2004-08-05 | Psinergi Corporation | Artificial nucleus pulposus and method of injecting same |
US20070003525A1 (en) * | 2003-01-31 | 2007-01-04 | Moehlenbruck Jeffrey W | Hydrogel compositions comprising nucleus pulposus tissue |
US7335203B2 (en) | 2003-02-12 | 2008-02-26 | Kyphon Inc. | System and method for immobilizing adjacent spinous processes |
AU2004212942A1 (en) | 2003-02-14 | 2004-09-02 | Depuy Spine, Inc. | In-situ formed intervertebral fusion device |
US6908484B2 (en) | 2003-03-06 | 2005-06-21 | Spinecore, Inc. | Cervical disc replacement |
US20040247867A1 (en) * | 2003-03-25 | 2004-12-09 | Hassan Chaouk | Hydrogel string medical device |
EP2060280A3 (en) | 2003-04-30 | 2009-05-27 | Drexel University | Thermogelling polymer blends for biomaterial applications |
TWI235055B (en) * | 2003-05-21 | 2005-07-01 | Guan-Gu Lin | Filling device capable of removing animal tissues |
TW587932B (en) * | 2003-05-21 | 2004-05-21 | Guan-Gu Lin | Removable animal tissue filling device |
AU2004245061A1 (en) | 2003-06-02 | 2004-12-16 | Warsaw Orthopedic, Inc. | Intervertebral disc implants and methods for manufacturing and using same |
ATE499910T1 (en) | 2003-06-20 | 2011-03-15 | Intrinsic Therapeutics Inc | DEVICE FOR DELIVERING AN IMPLANT THROUGH AN ANNUAL DEFECT IN A DISC |
US20050043796A1 (en) * | 2003-07-01 | 2005-02-24 | Grant Richard L. | Spinal disc nucleus implant |
US20050015150A1 (en) * | 2003-07-17 | 2005-01-20 | Lee Casey K. | Intervertebral disk and nucleus prosthesis |
US20060229729A1 (en) * | 2003-08-05 | 2006-10-12 | Gordon Charles R | Expandable intervertebral implant for use with instrument |
US7909869B2 (en) | 2003-08-05 | 2011-03-22 | Flexuspine, Inc. | Artificial spinal unit assemblies |
US7753958B2 (en) | 2003-08-05 | 2010-07-13 | Gordon Charles R | Expandable intervertebral implant |
US7799082B2 (en) | 2003-08-05 | 2010-09-21 | Flexuspine, Inc. | Artificial functional spinal unit system and method for use |
US7169405B2 (en) * | 2003-08-06 | 2007-01-30 | Warsaw Orthopedic, Inc. | Methods and devices for the treatment of intervertebral discs |
US20050055099A1 (en) * | 2003-09-09 | 2005-03-10 | Ku David N. | Flexible spinal disc |
TW200511970A (en) * | 2003-09-29 | 2005-04-01 | Kwan-Ku Lin | A spine wrapping and filling apparatus |
US7361183B2 (en) | 2003-10-17 | 2008-04-22 | Ensure Medical, Inc. | Locator and delivery device and method of use |
US8852229B2 (en) | 2003-10-17 | 2014-10-07 | Cordis Corporation | Locator and closure device and method of use |
US9445916B2 (en) | 2003-10-22 | 2016-09-20 | Pioneer Surgical Technology, Inc. | Joint arthroplasty devices having articulating members |
US7320707B2 (en) * | 2003-11-05 | 2008-01-22 | St. Francis Medical Technologies, Inc. | Method of laterally inserting an artificial vertebral disk replacement implant with crossbar spacer |
US7691146B2 (en) | 2003-11-21 | 2010-04-06 | Kyphon Sarl | Method of laterally inserting an artificial vertebral disk replacement implant with curved spacer |
US7217291B2 (en) | 2003-12-08 | 2007-05-15 | St. Francis Medical Technologies, Inc. | System and method for replacing degenerated spinal disks |
US20100063174A1 (en) * | 2004-02-04 | 2010-03-11 | Ruberti Jeffrey W | Systems and methods for controlling and forming polymer gels |
CA2558661C (en) | 2004-02-06 | 2012-09-04 | Georgia Tech Research Corporation | Load bearing biocompatible device |
WO2005077013A2 (en) | 2004-02-06 | 2005-08-25 | Georgia Tech Research Corporation | Surface directed cellular attachment |
US20060241339A1 (en) * | 2005-02-23 | 2006-10-26 | Cook Timothy C | Method and apparatus for an adjustable implantable continence device |
US8636802B2 (en) | 2004-03-06 | 2014-01-28 | DePuy Synthes Products, LLC | Dynamized interspinal implant |
JP2007530120A (en) * | 2004-03-26 | 2007-11-01 | ヌヴァシヴ インコーポレイテッド | Porous implant for spinal disc nucleus pulposus replacement |
JP4563449B2 (en) * | 2004-03-26 | 2010-10-13 | ヌヴァシヴ インコーポレイテッド | Artificial spinal disc |
US7282165B2 (en) * | 2004-04-27 | 2007-10-16 | Howmedica Osteonics Corp. | Wear resistant hydrogel for bearing applications |
US20060100304A1 (en) * | 2004-05-21 | 2006-05-11 | Synthes Inc. | Replacement or supplementation of a nucleus pulposus using a hydrogel |
US7585316B2 (en) | 2004-05-21 | 2009-09-08 | Warsaw Orthopedic, Inc. | Interspinous spacer |
US20050278023A1 (en) * | 2004-06-10 | 2005-12-15 | Zwirkoski Paul A | Method and apparatus for filling a cavity |
US20050278025A1 (en) * | 2004-06-10 | 2005-12-15 | Salumedica Llc | Meniscus prosthesis |
DE102004030347B4 (en) | 2004-06-18 | 2006-08-03 | Aesculap Ag & Co. Kg | implant |
JP4857268B2 (en) * | 2004-06-29 | 2012-01-18 | バイオキュア・インコーポレーテッド | Spinal disc nucleus pulposus graft |
EP1778134A1 (en) * | 2004-07-27 | 2007-05-02 | Synthes USA | Supplementation or replacement of a nucleus pulposus, of an intervertebral disc |
US20060036241A1 (en) * | 2004-08-11 | 2006-02-16 | Tzony Siegal | Spinal surgery system and method |
EP1793769A4 (en) | 2004-09-02 | 2009-06-24 | Crosstrees Medical Inc | Device and method for distraction of the spinal disc space |
US20060052870A1 (en) * | 2004-09-09 | 2006-03-09 | Ferree Bret A | Methods and apparatus to prevent movement through artificial disc replacements |
WO2006028370A1 (en) * | 2004-09-10 | 2006-03-16 | Stichting Dutch Polymer Institute | Radiopaque prosthetic intervertebral disc nucleus |
US7303074B2 (en) * | 2004-09-22 | 2007-12-04 | Dombrowski Trudy M | Foldable organizer device |
US8012209B2 (en) | 2004-09-23 | 2011-09-06 | Kyphon Sarl | Interspinous process implant including a binder, binder aligner and method of implantation |
US7235592B2 (en) | 2004-10-12 | 2007-06-26 | Zimmer Gmbh | PVA hydrogel |
US20060095134A1 (en) * | 2004-10-28 | 2006-05-04 | Sdgi Holdings, Inc. | Materials, devices and methods for implantation of transformable implants |
US20060106381A1 (en) * | 2004-11-18 | 2006-05-18 | Ferree Bret A | Methods and apparatus for treating spinal stenosis |
ATE524121T1 (en) | 2004-11-24 | 2011-09-15 | Abdou Samy | DEVICES FOR PLACING AN ORTHOPEDIC INTERVERTEBRAL IMPLANT |
US8029540B2 (en) | 2005-05-10 | 2011-10-04 | Kyphon Sarl | Inter-cervical facet implant with implantation tool |
US8100944B2 (en) | 2004-12-13 | 2012-01-24 | Kyphon Sarl | Inter-cervical facet implant and method for preserving the tissues surrounding the facet joint |
US7776090B2 (en) | 2004-12-13 | 2010-08-17 | Warsaw Orthopedic, Inc. | Inter-cervical facet implant and method |
ES2387194T3 (en) * | 2005-01-19 | 2012-09-17 | Nexgen Spine, Inc. | Fastening elastomer to rigid structures |
KR20070115886A (en) * | 2005-01-19 | 2007-12-06 | 넥스젠 스파인 인코포레이티드 | Elastomeric intervertebral disc prosthesis |
US8097018B2 (en) | 2005-02-17 | 2012-01-17 | Kyphon Sarl | Percutaneous spinal implants and methods |
US7998174B2 (en) | 2005-02-17 | 2011-08-16 | Kyphon Sarl | Percutaneous spinal implants and methods |
US7998208B2 (en) | 2005-02-17 | 2011-08-16 | Kyphon Sarl | Percutaneous spinal implants and methods |
US20070276373A1 (en) * | 2005-02-17 | 2007-11-29 | Malandain Hugues F | Percutaneous Spinal Implants and Methods |
US7993342B2 (en) | 2005-02-17 | 2011-08-09 | Kyphon Sarl | Percutaneous spinal implants and methods |
US8034080B2 (en) | 2005-02-17 | 2011-10-11 | Kyphon Sarl | Percutaneous spinal implants and methods |
US8096994B2 (en) | 2005-02-17 | 2012-01-17 | Kyphon Sarl | Percutaneous spinal implants and methods |
US20070276493A1 (en) | 2005-02-17 | 2007-11-29 | Malandain Hugues F | Percutaneous spinal implants and methods |
US7927354B2 (en) | 2005-02-17 | 2011-04-19 | Kyphon Sarl | Percutaneous spinal implants and methods |
US8057513B2 (en) | 2005-02-17 | 2011-11-15 | Kyphon Sarl | Percutaneous spinal implants and methods |
US8029567B2 (en) | 2005-02-17 | 2011-10-04 | Kyphon Sarl | Percutaneous spinal implants and methods |
US8096995B2 (en) | 2005-02-17 | 2012-01-17 | Kyphon Sarl | Percutaneous spinal implants and methods |
US8157841B2 (en) | 2005-02-17 | 2012-04-17 | Kyphon Sarl | Percutaneous spinal implants and methods |
US8100943B2 (en) | 2005-02-17 | 2012-01-24 | Kyphon Sarl | Percutaneous spinal implants and methods |
US8092459B2 (en) | 2005-02-17 | 2012-01-10 | Kyphon Sarl | Percutaneous spinal implants and methods |
US8007521B2 (en) * | 2005-02-17 | 2011-08-30 | Kyphon Sarl | Percutaneous spinal implants and methods |
US8043335B2 (en) * | 2005-02-17 | 2011-10-25 | Kyphon Sarl | Percutaneous spinal implants and methods |
US8038698B2 (en) | 2005-02-17 | 2011-10-18 | Kphon Sarl | Percutaneous spinal implants and methods |
US7988709B2 (en) | 2005-02-17 | 2011-08-02 | Kyphon Sarl | Percutaneous spinal implants and methods |
WO2006091706A1 (en) | 2005-02-23 | 2006-08-31 | Zimmer Technology, Inc. | Blend hydrogels and methods of making |
US7857856B2 (en) * | 2005-03-15 | 2010-12-28 | Warsaw Ortho Pedic, Inc. | Composite spinal nucleus implant with water absorption and swelling capabilities |
US7850730B2 (en) * | 2005-03-29 | 2010-12-14 | Synthes Usa, Llc | Method and apparatus for implanting a hydrogel prosthesis for a nucleus pulposus |
US8066742B2 (en) | 2005-03-31 | 2011-11-29 | Warsaw Orthopedic, Inc. | Intervertebral prosthetic device for spinal stabilization and method of implanting same |
US20060241757A1 (en) * | 2005-03-31 | 2006-10-26 | Sdgi Holdings, Inc. | Intervertebral prosthetic device for spinal stabilization and method of manufacturing same |
US7862590B2 (en) | 2005-04-08 | 2011-01-04 | Warsaw Orthopedic, Inc. | Interspinous process spacer |
US7780709B2 (en) | 2005-04-12 | 2010-08-24 | Warsaw Orthopedic, Inc. | Implants and methods for inter-transverse process dynamic stabilization of a spinal motion segment |
US8034079B2 (en) | 2005-04-12 | 2011-10-11 | Warsaw Orthopedic, Inc. | Implants and methods for posterior dynamic stabilization of a spinal motion segment |
US7789898B2 (en) * | 2005-04-15 | 2010-09-07 | Warsaw Orthopedic, Inc. | Transverse process/laminar spacer |
US7674296B2 (en) | 2005-04-21 | 2010-03-09 | Globus Medical, Inc. | Expandable vertebral prosthesis |
US7182783B2 (en) * | 2005-04-25 | 2007-02-27 | Sdgi Holdings, Inc. | Selectively expandable composite structures for spinal arthroplasty |
US20060247781A1 (en) * | 2005-04-29 | 2006-11-02 | Sdgi Holdings, Inc. | Implant |
US20060247623A1 (en) * | 2005-04-29 | 2006-11-02 | Sdgi Holdings, Inc. | Local delivery of an active agent from an orthopedic implant |
US7608108B2 (en) | 2005-04-29 | 2009-10-27 | Jmea Corporation | Tissue repair system |
US8702718B2 (en) | 2005-04-29 | 2014-04-22 | Jmea Corporation | Implantation system for tissue repair |
US7632313B2 (en) | 2005-04-29 | 2009-12-15 | Jmea Corporation | Disc repair system |
US7727233B2 (en) | 2005-04-29 | 2010-06-01 | Warsaw Orthopedic, Inc. | Spinous process stabilization devices and methods |
FR2885032B1 (en) * | 2005-04-29 | 2007-07-27 | Sdgi Holdings Inc | KIT AND INSTRUMENTATION FOR EXECUTING A SPINAL IMPLANTATION PROCEDURE |
US8088144B2 (en) | 2005-05-04 | 2012-01-03 | Ensure Medical, Inc. | Locator and closure device and method of use |
US8926654B2 (en) | 2005-05-04 | 2015-01-06 | Cordis Corporation | Locator and closure device and method of use |
FR2886537B1 (en) * | 2005-06-02 | 2008-06-13 | Spinevision Sa | NUCLEUS PROSTHESIS OF AN INTERVERTEBRAL DISC |
GB0514891D0 (en) * | 2005-07-20 | 2005-08-24 | Pearsalls Ltd | Improvements in and relating to implants |
US20060276899A1 (en) * | 2005-06-03 | 2006-12-07 | Zipnick Richard I | Minimally invasive apparatus to manipulate and revitalize spinal column disc |
JP4857437B2 (en) * | 2005-06-13 | 2012-01-18 | 日本メディカルマテリアル株式会社 | Spinal disc replacement material for nucleus pulposus and method for producing the same |
EP1895947A2 (en) * | 2005-06-17 | 2008-03-12 | Abbott Laboratories | Improved method of treating degenerative spinal disorders |
US8080061B2 (en) * | 2005-06-20 | 2011-12-20 | Synthes Usa, Llc | Apparatus and methods for treating bone |
FR2887434B1 (en) | 2005-06-28 | 2008-03-28 | Jean Taylor | SURGICAL TREATMENT EQUIPMENT OF TWO VERTEBRATES |
US20070010889A1 (en) * | 2005-07-06 | 2007-01-11 | Sdgi Holdings, Inc. | Foldable nucleus replacement device |
US20090254132A1 (en) * | 2005-07-07 | 2009-10-08 | Scribner Robert M | Devices and methods for the treatment of bone fracture |
WO2007008983A2 (en) * | 2005-07-11 | 2007-01-18 | Kyphon, Inc. | Systems and methods for providing prostheses |
US8454617B2 (en) | 2005-08-16 | 2013-06-04 | Benvenue Medical, Inc. | Devices for treating the spine |
AU2006279558B2 (en) | 2005-08-16 | 2012-05-17 | Izi Medical Products, Llc | Spinal tissue distraction devices |
US8366773B2 (en) | 2005-08-16 | 2013-02-05 | Benvenue Medical, Inc. | Apparatus and method for treating bone |
ZA200802596B (en) * | 2005-08-26 | 2009-03-25 | Synthes Gmbh | Hydrogel balloon prosthesis for nucleus pulposus |
US20070073397A1 (en) * | 2005-09-15 | 2007-03-29 | Mckinley Laurence M | Disc nucleus prosthesis and its method of insertion and revision |
US8167915B2 (en) | 2005-09-28 | 2012-05-01 | Nuvasive, Inc. | Methods and apparatus for treating spinal stenosis |
CA2627345A1 (en) | 2005-10-24 | 2007-05-03 | Nexgen Spine, Inc. | Intervertebral disc replacement and associated instrumentation |
US20070093906A1 (en) * | 2005-10-26 | 2007-04-26 | Zimmer Spine, Inc. | Nucleus implant and method |
US8357181B2 (en) | 2005-10-27 | 2013-01-22 | Warsaw Orthopedic, Inc. | Intervertebral prosthetic device for spinal stabilization and method of implanting same |
US7862591B2 (en) | 2005-11-10 | 2011-01-04 | Warsaw Orthopedic, Inc. | Intervertebral prosthetic device for spinal stabilization and method of implanting same |
US20070118218A1 (en) * | 2005-11-22 | 2007-05-24 | Hooper David M | Facet joint implant and procedure |
US8262730B2 (en) | 2005-12-07 | 2012-09-11 | Zimmer, Inc. | Methods of bonding or modifying hydrogels using irradiation |
AU2006322455B2 (en) | 2005-12-08 | 2012-04-12 | Fbcdevice Aps | Disc implant |
US20070141108A1 (en) * | 2005-12-20 | 2007-06-21 | Zimmer, Inc. | Fiber-reinforced water-swellable articles |
DE602006017160D1 (en) | 2005-12-22 | 2010-11-11 | Zimmer Inc | Perfluorocyclobutane crosslinked hydrogels |
US20070162132A1 (en) | 2005-12-23 | 2007-07-12 | Dominique Messerli | Flexible elongated chain implant and method of supporting body tissue with same |
US8506633B2 (en) * | 2005-12-27 | 2013-08-13 | Warsaw Orthopedic, Inc. | Rehydration and restoration of intervertebral discs with polyelectrolytes |
US8801790B2 (en) * | 2005-12-27 | 2014-08-12 | Warsaw Orthopedic, Inc. | Intervertebral disc augmentation and rehydration with superabsorbent polymers |
US7645301B2 (en) * | 2006-01-13 | 2010-01-12 | Zimmer Spine, Inc. | Devices and methods for disc replacement |
US20070173823A1 (en) | 2006-01-18 | 2007-07-26 | Sdgi Holdings, Inc. | Intervertebral prosthetic device for spinal stabilization and method of implanting same |
US8083795B2 (en) | 2006-01-18 | 2011-12-27 | Warsaw Orthopedic, Inc. | Intervertebral prosthetic device for spinal stabilization and method of manufacturing same |
US7837711B2 (en) | 2006-01-27 | 2010-11-23 | Warsaw Orthopedic, Inc. | Artificial spinous process for the sacrum and methods of use |
US7691130B2 (en) | 2006-01-27 | 2010-04-06 | Warsaw Orthopedic, Inc. | Spinal implants including a sensor and methods of use |
US7682376B2 (en) | 2006-01-27 | 2010-03-23 | Warsaw Orthopedic, Inc. | Interspinous devices and methods of use |
WO2007095333A2 (en) * | 2006-02-15 | 2007-08-23 | Abdou M S | Devices and methods for inter-vertebral orthopedic device placement |
US20070233251A1 (en) * | 2006-02-18 | 2007-10-04 | Abdou M S | Use of Magnetic Fields in Orthopedic Implants |
US8118869B2 (en) | 2006-03-08 | 2012-02-21 | Flexuspine, Inc. | Dynamic interbody device |
US8262698B2 (en) | 2006-03-16 | 2012-09-11 | Warsaw Orthopedic, Inc. | Expandable device for insertion between anatomical structures and a procedure utilizing same |
US8110242B2 (en) | 2006-03-24 | 2012-02-07 | Zimmer, Inc. | Methods of preparing hydrogel coatings |
US7985246B2 (en) | 2006-03-31 | 2011-07-26 | Warsaw Orthopedic, Inc. | Methods and instruments for delivering interspinous process spacers |
US8303660B1 (en) | 2006-04-22 | 2012-11-06 | Samy Abdou | Inter-vertebral disc prosthesis with variable rotational stop and methods of use |
US7879027B2 (en) * | 2006-04-24 | 2011-02-01 | Warsaw Orthopedic, Inc. | Controlled release devices for fusion of osteal structures |
US8642059B2 (en) * | 2006-04-24 | 2014-02-04 | Warsaw Orthopedic, Inc. | Controlled release systems and methods for intervertebral discs |
US7771414B2 (en) * | 2006-04-24 | 2010-08-10 | Warsaw Orthopedic, Inc. | Controlled release devices for therapeutic treatments of spinal discs |
US8118844B2 (en) | 2006-04-24 | 2012-02-21 | Warsaw Orthopedic, Inc. | Expandable device for insertion between anatomical structures and a procedure utilizing same |
US8642060B2 (en) * | 2006-04-24 | 2014-02-04 | Warsaw Orthopedic, Inc. | Controlled release systems and methods for osteal growth |
US8105357B2 (en) | 2006-04-28 | 2012-01-31 | Warsaw Orthopedic, Inc. | Interspinous process brace |
US7846185B2 (en) | 2006-04-28 | 2010-12-07 | Warsaw Orthopedic, Inc. | Expandable interspinous process implant and method of installing same |
US20070270823A1 (en) | 2006-04-28 | 2007-11-22 | Sdgi Holdings, Inc. | Multi-chamber expandable interspinous process brace |
US8252031B2 (en) | 2006-04-28 | 2012-08-28 | Warsaw Orthopedic, Inc. | Molding device for an expandable interspinous process implant |
US8048118B2 (en) | 2006-04-28 | 2011-11-01 | Warsaw Orthopedic, Inc. | Adjustable interspinous process brace |
US8348978B2 (en) | 2006-04-28 | 2013-01-08 | Warsaw Orthopedic, Inc. | Interosteotic implant |
US8062337B2 (en) | 2006-05-04 | 2011-11-22 | Warsaw Orthopedic, Inc. | Expandable device for insertion between anatomical structures and a procedure utilizing same |
US8147517B2 (en) | 2006-05-23 | 2012-04-03 | Warsaw Orthopedic, Inc. | Systems and methods for adjusting properties of a spinal implant |
US20070276496A1 (en) | 2006-05-23 | 2007-11-29 | Sdgi Holdings, Inc. | Surgical spacer with shape control |
US8771355B2 (en) * | 2006-05-26 | 2014-07-08 | M. S. Abdou | Inter-vertebral disc motion devices and methods of use |
WO2010062971A1 (en) | 2008-11-26 | 2010-06-03 | Anova Corporation | Methods and apparatus for anulus repair |
US20070280986A1 (en) * | 2006-06-01 | 2007-12-06 | Carlos Gil | Intra-operative coating of implants |
US8764835B2 (en) | 2006-06-13 | 2014-07-01 | Bret A. Ferree | Intervertebral disc treatment methods and apparatus |
US8834496B2 (en) | 2006-06-13 | 2014-09-16 | Bret A. Ferree | Soft tissue repair methods and apparatus |
US9232938B2 (en) | 2006-06-13 | 2016-01-12 | Anova Corp. | Method and apparatus for closing fissures in the annulus fibrosus |
US8118779B2 (en) | 2006-06-30 | 2012-02-21 | Warsaw Orthopedic, Inc. | Collagen delivery device |
US8399619B2 (en) | 2006-06-30 | 2013-03-19 | Warsaw Orthopedic, Inc. | Injectable collagen material |
US8048119B2 (en) | 2006-07-20 | 2011-11-01 | Warsaw Orthopedic, Inc. | Apparatus for insertion between anatomical structures and a procedure utilizing same |
US20080026032A1 (en) * | 2006-07-27 | 2008-01-31 | Zubery Yuval | Composite implants for promoting bone regeneration and augmentation and methods for their preparation and use |
US7758649B2 (en) * | 2006-08-04 | 2010-07-20 | Integrity Intellect Inc. | Reversibly deformable implant |
US8834526B2 (en) * | 2006-08-09 | 2014-09-16 | Rolando Garcia | Methods and apparatus for treating spinal stenosis |
US20080039942A1 (en) * | 2006-08-11 | 2008-02-14 | Bergeron Brian J | Spinal implant |
US20080086115A1 (en) | 2006-09-07 | 2008-04-10 | Warsaw Orthopedic, Inc. | Intercostal spacer device and method for use in correcting a spinal deformity |
US8715350B2 (en) | 2006-09-15 | 2014-05-06 | Pioneer Surgical Technology, Inc. | Systems and methods for securing an implant in intervertebral space |
WO2008039850A2 (en) | 2006-09-26 | 2008-04-03 | Nexgen Spine, Inc. | Intervertebral. prosthesis endplate having double dome and surgical tools for preparing the vertebral body endplate to receive the prosthesis |
US8066750B2 (en) | 2006-10-06 | 2011-11-29 | Warsaw Orthopedic, Inc | Port structures for non-rigid bone plates |
US8097019B2 (en) * | 2006-10-24 | 2012-01-17 | Kyphon Sarl | Systems and methods for in situ assembly of an interspinous process distraction implant |
FR2908035B1 (en) | 2006-11-08 | 2009-05-01 | Jean Taylor | INTEREPINE IMPLANT |
US20080114358A1 (en) * | 2006-11-13 | 2008-05-15 | Warsaw Orthopedic, Inc. | Intervertebral Prosthetic Assembly for Spinal Stabilization and Method of Implanting Same |
US20080114357A1 (en) * | 2006-11-15 | 2008-05-15 | Warsaw Orthopedic, Inc. | Inter-transverse process spacer device and method for use in correcting a spinal deformity |
US7879104B2 (en) | 2006-11-15 | 2011-02-01 | Warsaw Orthopedic, Inc. | Spinal implant system |
JP5115866B2 (en) | 2006-11-16 | 2013-01-09 | レックス メディカル リミテッド パートナーシップ | Spine implant and method of using the same |
US11395626B2 (en) | 2006-12-07 | 2022-07-26 | DePuy Synthes Products, Inc. | Sensor for intervertebral fusion indicia |
US8105382B2 (en) | 2006-12-07 | 2012-01-31 | Interventional Spine, Inc. | Intervertebral implant |
US7955392B2 (en) | 2006-12-14 | 2011-06-07 | Warsaw Orthopedic, Inc. | Interspinous process devices and methods |
US7905922B2 (en) | 2006-12-20 | 2011-03-15 | Zimmer Spine, Inc. | Surgical implant suitable for replacement of an intervertebral disc |
US8974496B2 (en) | 2007-08-30 | 2015-03-10 | Jeffrey Chun Wang | Interspinous implant, tools and methods of implanting |
US9066811B2 (en) | 2007-01-19 | 2015-06-30 | Flexuspine, Inc. | Artificial functional spinal unit system and method for use |
EP2124777A4 (en) | 2007-02-21 | 2013-06-05 | Benvenue Medical Inc | Devices for treating the spine |
US9034039B2 (en) * | 2007-03-07 | 2015-05-19 | Ulrich Gmbh & Co.Kg | Intervertebral implant with elastic part |
US20080269897A1 (en) * | 2007-04-26 | 2008-10-30 | Abhijeet Joshi | Implantable device and methods for repairing articulating joints for using the same |
US20080268056A1 (en) * | 2007-04-26 | 2008-10-30 | Abhijeet Joshi | Injectable copolymer hydrogel useful for repairing vertebral compression fractures |
US8840646B2 (en) | 2007-05-10 | 2014-09-23 | Warsaw Orthopedic, Inc. | Spinous process implants and methods |
US20080294199A1 (en) * | 2007-05-25 | 2008-11-27 | Andrew Kohm | Spinous process implants and methods of using the same |
US8900307B2 (en) | 2007-06-26 | 2014-12-02 | DePuy Synthes Products, LLC | Highly lordosed fusion cage |
US8092541B2 (en) * | 2007-08-03 | 2012-01-10 | Warsaw Orthopedic, Inc. | Method of using an anti-growth matrix as a barrier for cell attachment and osteo-inductive factors |
US7731988B2 (en) | 2007-08-03 | 2010-06-08 | Zimmer, Inc. | Multi-polymer hydrogels |
US8282681B2 (en) * | 2007-08-13 | 2012-10-09 | Nuvasive, Inc. | Bioresorbable spinal implant and related methods |
US8348976B2 (en) | 2007-08-27 | 2013-01-08 | Kyphon Sarl | Spinous-process implants and methods of using the same |
US8062739B2 (en) | 2007-08-31 | 2011-11-22 | Zimmer, Inc. | Hydrogels with gradient |
US20110196492A1 (en) | 2007-09-07 | 2011-08-11 | Intrinsic Therapeutics, Inc. | Bone anchoring systems |
EP2195087A1 (en) * | 2007-09-14 | 2010-06-16 | Crosstrees Medical, Inc. | Material control device for inserting material into a targeted anatomical region |
US8267965B2 (en) | 2007-10-22 | 2012-09-18 | Flexuspine, Inc. | Spinal stabilization systems with dynamic interbody devices |
US8187330B2 (en) * | 2007-10-22 | 2012-05-29 | Flexuspine, Inc. | Dampener system for a posterior stabilization system with a variable length elongated member |
US8523912B2 (en) | 2007-10-22 | 2013-09-03 | Flexuspine, Inc. | Posterior stabilization systems with shared, dual dampener systems |
US8162994B2 (en) | 2007-10-22 | 2012-04-24 | Flexuspine, Inc. | Posterior stabilization system with isolated, dual dampener systems |
US8182514B2 (en) | 2007-10-22 | 2012-05-22 | Flexuspine, Inc. | Dampener system for a posterior stabilization system with a fixed length elongated member |
US8157844B2 (en) | 2007-10-22 | 2012-04-17 | Flexuspine, Inc. | Dampener system for a posterior stabilization system with a variable length elongated member |
US7947784B2 (en) | 2007-11-16 | 2011-05-24 | Zimmer, Inc. | Reactive compounding of hydrogels |
US8034362B2 (en) | 2008-01-04 | 2011-10-11 | Zimmer, Inc. | Chemical composition of hydrogels for use as articulating surfaces |
CN101909548B (en) | 2008-01-17 | 2014-07-30 | 斯恩蒂斯有限公司 | An expandable intervertebral implant and associated method of manufacturing the same |
US7763268B2 (en) * | 2008-01-18 | 2010-07-27 | The Research Foundation Of State University Of New York | Load bearing hydrogel implants |
US8105358B2 (en) | 2008-02-04 | 2012-01-31 | Kyphon Sarl | Medical implants and methods |
US20090222098A1 (en) * | 2008-02-28 | 2009-09-03 | Warsaw Orthopedics, Inc. | Spinal nucleus replacement with varying modulus |
US8114136B2 (en) | 2008-03-18 | 2012-02-14 | Warsaw Orthopedic, Inc. | Implants and methods for inter-spinous process dynamic stabilization of a spinal motion segment |
US8202299B2 (en) | 2008-03-19 | 2012-06-19 | Collabcom II, LLC | Interspinous implant, tools and methods of implanting |
US8377135B1 (en) | 2008-03-31 | 2013-02-19 | Nuvasive, Inc. | Textile-based surgical implant and related methods |
WO2009124269A1 (en) | 2008-04-05 | 2009-10-08 | Synthes Usa, Llc | Expandable intervertebral implant |
GB0807154D0 (en) * | 2008-04-18 | 2008-05-21 | Univ Aston | Intervertebral disc |
US20110125158A1 (en) | 2008-05-01 | 2011-05-26 | Ashish Dhar Diwan | Systems, methods and apparatuses for formation and insertion of tissue prostheses |
US8470045B2 (en) | 2008-05-05 | 2013-06-25 | K2M, Inc. | Endplate for an intervertebral prosthesis and prosthesis incorporating the same |
ES2361099B1 (en) * | 2008-05-26 | 2012-05-08 | Rudolf Morgenstern Lopez | "INTERVERTEBRAL PROSTHESIS" |
US20090297603A1 (en) * | 2008-05-29 | 2009-12-03 | Abhijeet Joshi | Interspinous dynamic stabilization system with anisotropic hydrogels |
US8114156B2 (en) * | 2008-05-30 | 2012-02-14 | Edwin Burton Hatch | Flexibly compliant ceramic prosthetic meniscus for the replacement of damaged cartilage in orthopedic surgical repair or reconstruction of hip, knee, ankle, shoulder, elbow, wrist and other anatomical joints |
US8163022B2 (en) | 2008-10-14 | 2012-04-24 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US8114131B2 (en) | 2008-11-05 | 2012-02-14 | Kyphon Sarl | Extension limiting devices and methods of use for the spine |
US8721723B2 (en) | 2009-01-12 | 2014-05-13 | Globus Medical, Inc. | Expandable vertebral prosthesis |
US8114135B2 (en) | 2009-01-16 | 2012-02-14 | Kyphon Sarl | Adjustable surgical cables and methods for treating spinal stenosis |
US8535327B2 (en) | 2009-03-17 | 2013-09-17 | Benvenue Medical, Inc. | Delivery apparatus for use with implantable medical devices |
US9526620B2 (en) | 2009-03-30 | 2016-12-27 | DePuy Synthes Products, Inc. | Zero profile spinal fusion cage |
US8372117B2 (en) | 2009-06-05 | 2013-02-12 | Kyphon Sarl | Multi-level interspinous implants and methods of use |
US8157842B2 (en) | 2009-06-12 | 2012-04-17 | Kyphon Sarl | Interspinous implant and methods of use |
US8211126B2 (en) | 2009-09-22 | 2012-07-03 | Jmea Corporation | Tissue repair system |
US8771317B2 (en) | 2009-10-28 | 2014-07-08 | Warsaw Orthopedic, Inc. | Interspinous process implant and method of implantation |
US8764806B2 (en) | 2009-12-07 | 2014-07-01 | Samy Abdou | Devices and methods for minimally invasive spinal stabilization and instrumentation |
US9393129B2 (en) | 2009-12-10 | 2016-07-19 | DePuy Synthes Products, Inc. | Bellows-like expandable interbody fusion cage |
US8652153B2 (en) | 2010-01-11 | 2014-02-18 | Anulex Technologies, Inc. | Intervertebral disc annulus repair system and bone anchor delivery tool |
US8317831B2 (en) | 2010-01-13 | 2012-11-27 | Kyphon Sarl | Interspinous process spacer diagnostic balloon catheter and methods of use |
US8114132B2 (en) | 2010-01-13 | 2012-02-14 | Kyphon Sarl | Dynamic interspinous process device |
US8147526B2 (en) | 2010-02-26 | 2012-04-03 | Kyphon Sarl | Interspinous process spacer diagnostic parallel balloon catheter and methods of use |
US9301850B2 (en) | 2010-04-12 | 2016-04-05 | Globus Medical, Inc. | Expandable vertebral implant |
US8282683B2 (en) | 2010-04-12 | 2012-10-09 | Globus Medical, Inc. | Expandable vertebral implant |
US8591585B2 (en) | 2010-04-12 | 2013-11-26 | Globus Medical, Inc. | Expandable vertebral implant |
US8870880B2 (en) | 2010-04-12 | 2014-10-28 | Globus Medical, Inc. | Angling inserter tool for expandable vertebral implant |
US9907560B2 (en) | 2010-06-24 | 2018-03-06 | DePuy Synthes Products, Inc. | Flexible vertebral body shavers |
US8979860B2 (en) | 2010-06-24 | 2015-03-17 | DePuy Synthes Products. LLC | Enhanced cage insertion device |
TW201215379A (en) | 2010-06-29 | 2012-04-16 | Synthes Gmbh | Distractible intervertebral implant |
US8814908B2 (en) | 2010-07-26 | 2014-08-26 | Warsaw Orthopedic, Inc. | Injectable flexible interspinous process device system |
US9402732B2 (en) | 2010-10-11 | 2016-08-02 | DePuy Synthes Products, Inc. | Expandable interspinous process spacer implant |
US8562650B2 (en) | 2011-03-01 | 2013-10-22 | Warsaw Orthopedic, Inc. | Percutaneous spinous process fusion plate assembly and method |
US8388687B2 (en) | 2011-03-25 | 2013-03-05 | Flexuspine, Inc. | Interbody device insertion systems and methods |
US8591548B2 (en) | 2011-03-31 | 2013-11-26 | Warsaw Orthopedic, Inc. | Spinous process fusion plate assembly |
US8591549B2 (en) | 2011-04-08 | 2013-11-26 | Warsaw Orthopedic, Inc. | Variable durometer lumbar-sacral implant |
EP2757964B1 (en) | 2011-05-26 | 2016-05-04 | Cartiva, Inc. | Tapered joint implant and related tools |
WO2012178018A2 (en) | 2011-06-24 | 2012-12-27 | Benvenue Medical, Inc. | Devices and methods for treating bone tissue |
US8845728B1 (en) | 2011-09-23 | 2014-09-30 | Samy Abdou | Spinal fixation devices and methods of use |
US9526627B2 (en) | 2011-11-17 | 2016-12-27 | Exactech, Inc. | Expandable interbody device system and method |
EP3011918B1 (en) | 2011-12-03 | 2018-07-25 | DePuy Synthes Products, Inc. | Safe cutting heads and systems for fast removal of a target tissue |
US9241807B2 (en) | 2011-12-23 | 2016-01-26 | Pioneer Surgical Technology, Inc. | Systems and methods for inserting a spinal device |
US20130226240A1 (en) | 2012-02-22 | 2013-08-29 | Samy Abdou | Spinous process fixation devices and methods of use |
US20130282121A1 (en) * | 2012-03-22 | 2013-10-24 | Ann Prewett | Spinal facet augmentation implant and method |
US10350072B2 (en) | 2012-05-24 | 2019-07-16 | Cartiva, Inc. | Tooling for creating tapered opening in tissue and related methods |
WO2014018098A1 (en) | 2012-07-26 | 2014-01-30 | DePuy Synthes Products, LLC | Expandable implant |
US9198767B2 (en) | 2012-08-28 | 2015-12-01 | Samy Abdou | Devices and methods for spinal stabilization and instrumentation |
US20140067069A1 (en) | 2012-08-30 | 2014-03-06 | Interventional Spine, Inc. | Artificial disc |
US9320617B2 (en) | 2012-10-22 | 2016-04-26 | Cogent Spine, LLC | Devices and methods for spinal stabilization and instrumentation |
US10786235B2 (en) | 2012-10-31 | 2020-09-29 | Anchor Innovation Medical, Inc. | Method and apparatus for closing a fissure in the annulus of an intervertebral disc, and/or for effecting other anatomical repairs and/or fixations |
US9433404B2 (en) | 2012-10-31 | 2016-09-06 | Suture Concepts Inc. | Method and apparatus for closing fissures in the annulus fibrosus |
US9737294B2 (en) | 2013-01-28 | 2017-08-22 | Cartiva, Inc. | Method and system for orthopedic repair |
WO2014117107A1 (en) | 2013-01-28 | 2014-07-31 | Cartiva, Inc. | Systems and methods for orthopedic repair |
CN103099689B (en) * | 2013-02-19 | 2015-08-26 | 哈尔滨朝阳滨辉实业发展集团有限公司 | The Minimally Invasive Surgery preparation method of spiral nucleus prosthesis and application |
US9492288B2 (en) | 2013-02-20 | 2016-11-15 | Flexuspine, Inc. | Expandable fusion device for positioning between adjacent vertebral bodies |
US9522070B2 (en) | 2013-03-07 | 2016-12-20 | Interventional Spine, Inc. | Intervertebral implant |
US9913728B2 (en) | 2013-03-14 | 2018-03-13 | Quandary Medical, Llc | Spinal implants and implantation system |
US10085783B2 (en) | 2013-03-14 | 2018-10-02 | Izi Medical Products, Llc | Devices and methods for treating bone tissue |
CN105578975A (en) | 2013-07-19 | 2016-05-11 | 欧罗波罗斯医学有限公司 | An anti-clogging device for a vacuum-assisted, tissue removal system |
WO2015024013A2 (en) | 2013-08-16 | 2015-02-19 | Suture Concepts Inc. | Method and apparatus for closing a fissure in the annulus of an intervertebral disc, and/or for effecting other anatomical repairs and/or fixations |
US9517144B2 (en) | 2014-04-24 | 2016-12-13 | Exactech, Inc. | Limited profile intervertebral implant with incorporated fastening mechanism |
US10398565B2 (en) | 2014-04-24 | 2019-09-03 | Choice Spine, Llc | Limited profile intervertebral implant with incorporated fastening and locking mechanism |
AU2015360469B2 (en) * | 2014-12-10 | 2021-03-25 | Incept, Llc | Hydrogel drug delivery implants |
US11426290B2 (en) | 2015-03-06 | 2022-08-30 | DePuy Synthes Products, Inc. | Expandable intervertebral implant, system, kit and method |
EP3892241A1 (en) | 2015-03-31 | 2021-10-13 | Cartiva, Inc. | Drill bit for carpometacarpal implant |
WO2016161025A1 (en) | 2015-03-31 | 2016-10-06 | Cartiva, Inc. | Hydrogel implants with porous materials and methods |
US9913727B2 (en) | 2015-07-02 | 2018-03-13 | Medos International Sarl | Expandable implant |
US10857003B1 (en) | 2015-10-14 | 2020-12-08 | Samy Abdou | Devices and methods for vertebral stabilization |
US10561504B2 (en) | 2016-01-19 | 2020-02-18 | K2M, Inc. | Surgical instrument and methods of use thereof |
JP7019616B2 (en) | 2016-06-28 | 2022-02-15 | イーアイティー・エマージング・インプラント・テクノロジーズ・ゲーエムベーハー | Expandable and angle adjustable intervertebral cage with range of motion joints |
JP6995789B2 (en) | 2016-06-28 | 2022-01-17 | イーアイティー・エマージング・インプラント・テクノロジーズ・ゲーエムベーハー | Expandable and angle adjustable intervertebral cage |
US10744000B1 (en) | 2016-10-25 | 2020-08-18 | Samy Abdou | Devices and methods for vertebral bone realignment |
US10973648B1 (en) | 2016-10-25 | 2021-04-13 | Samy Abdou | Devices and methods for vertebral bone realignment |
US10537436B2 (en) | 2016-11-01 | 2020-01-21 | DePuy Synthes Products, Inc. | Curved expandable cage |
US10888433B2 (en) | 2016-12-14 | 2021-01-12 | DePuy Synthes Products, Inc. | Intervertebral implant inserter and related methods |
US10398563B2 (en) | 2017-05-08 | 2019-09-03 | Medos International Sarl | Expandable cage |
US11344424B2 (en) | 2017-06-14 | 2022-05-31 | Medos International Sarl | Expandable intervertebral implant and related methods |
US10940016B2 (en) | 2017-07-05 | 2021-03-09 | Medos International Sarl | Expandable intervertebral fusion cage |
JP2020533070A (en) | 2017-09-08 | 2020-11-19 | パイオニア サージカル テクノロジー インコーポレイテッド | Intervertebral implants, instruments, and methods |
USD907771S1 (en) | 2017-10-09 | 2021-01-12 | Pioneer Surgical Technology, Inc. | Intervertebral implant |
US11179248B2 (en) | 2018-10-02 | 2021-11-23 | Samy Abdou | Devices and methods for spinal implantation |
US11446156B2 (en) | 2018-10-25 | 2022-09-20 | Medos International Sarl | Expandable intervertebral implant, inserter instrument, and related methods |
US11510766B2 (en) | 2019-02-14 | 2022-11-29 | Uromedica, Inc. | Method and apparatus for monitoring implantable device for urinary continence |
US11426286B2 (en) | 2020-03-06 | 2022-08-30 | Eit Emerging Implant Technologies Gmbh | Expandable intervertebral implant |
CN113143548B (en) * | 2021-03-22 | 2023-09-22 | 上海交通大学医学院附属第九人民医院 | Artificial intervertebral disc tissue, construction method, preparation method, computer readable storage medium and equipment |
US11850160B2 (en) | 2021-03-26 | 2023-12-26 | Medos International Sarl | Expandable lordotic intervertebral fusion cage |
US11752009B2 (en) | 2021-04-06 | 2023-09-12 | Medos International Sarl | Expandable intervertebral fusion cage |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3607848A (en) * | 1967-08-07 | 1971-09-21 | Ceskoslovenska Akademie Ved | Method for preparing insoluble,cross-linked organic hydrogels comprising copolymers of glycol monoesters with diesters |
CA992255A (en) | 1971-01-25 | 1976-07-06 | Cutter Laboratories | Prosthesis for spinal repair |
US3875595A (en) | 1974-04-15 | 1975-04-08 | Edward C Froning | Intervertebral disc prosthesis and instruments for locating same |
CA1146301A (en) | 1980-06-13 | 1983-05-17 | J. David Kuntz | Intervertebral disc prosthesis |
US4420589A (en) | 1980-07-07 | 1983-12-13 | Stoy Vladimir A | Polymer composition including polyacrylonitrile polymers and process for preparing same |
US4370451A (en) | 1980-07-07 | 1983-01-25 | S.K.Y. Polymers | Novel block copolymers including acrylonitrile sequences and sequences including units derived from glutarimide units and processes for preparing same |
US4337327A (en) | 1980-07-07 | 1982-06-29 | S.K.Y. Polymers, Inc. | Novel block copolymers including acrylonitrile sequences and sequences including units derived from glutarimide units and processes for preparing same |
US4379874A (en) | 1980-07-07 | 1983-04-12 | Stoy Vladimir A | Polymer composition comprising polyacrylonitrile polymer and multi-block copolymer |
US4331783A (en) | 1980-09-17 | 1982-05-25 | S.K.Y. Polymers | Novel block copolymers including acrylonitrile sequences and glutarimide units and processes for preparing same |
US4369294A (en) | 1980-09-17 | 1983-01-18 | S.K.Y. Polmers | Novel block copolymers including acrylonitrile sequences and glutarimide units and processes for preparing same |
US4309777A (en) | 1980-11-13 | 1982-01-12 | Patil Arun A | Artificial intervertebral disc |
US4631188A (en) | 1983-08-31 | 1986-12-23 | S.K.Y. Polymers, Ltd. (Kingston Technologies) | Injectable physiologically-acceptable polymeric composition |
JPH0678460B2 (en) | 1985-05-01 | 1994-10-05 | 株式会社バイオマテリアル・ユニバース | Porous transparent polyvinyl alcohol gel |
CH671691A5 (en) | 1987-01-08 | 1989-09-29 | Sulzer Ag | |
US4714469A (en) | 1987-02-26 | 1987-12-22 | Pfizer Hospital Products Group, Inc. | Spinal implant |
US4863477A (en) * | 1987-05-12 | 1989-09-05 | Monson Gary L | Synthetic intervertebral disc prosthesis |
US5258043A (en) * | 1987-07-20 | 1993-11-02 | Regen Corporation | Method for making a prosthetic intervertebral disc |
US4772287A (en) * | 1987-08-20 | 1988-09-20 | Cedar Surgical, Inc. | Prosthetic disc and method of implanting |
US4911718A (en) | 1988-06-10 | 1990-03-27 | University Of Medicine & Dentistry Of N.J. | Functional and biocompatible intervertebral disc spacer |
AU624627B2 (en) * | 1988-08-18 | 1992-06-18 | Johnson & Johnson Orthopaedics, Inc. | Functional and biocompatible intervertebral disc spacer containing elastomeric material of varying hardness |
WO1990009152A1 (en) * | 1989-02-15 | 1990-08-23 | Microtek Medical, Inc. | Biocompatible material and prosthesis |
DE59100448D1 (en) * | 1990-04-20 | 1993-11-11 | Sulzer Ag | Implant, in particular intervertebral prosthesis. |
US5192326A (en) | 1990-12-21 | 1993-03-09 | Pfizer Hospital Products Group, Inc. | Hydrogel bead intervertebral disc nucleus |
US5047055A (en) | 1990-12-21 | 1991-09-10 | Pfizer Hospital Products Group, Inc. | Hydrogel intervertebral disc nucleus |
JP3007903B2 (en) * | 1991-03-29 | 2000-02-14 | 京セラ株式会社 | Artificial disc |
IT1259100B (en) * | 1992-05-20 | 1996-03-11 | Lanfranco Callegaro | USE OF HYDROGELS FOR THE LOCKING OF PROSTHETIC SYSTEMS |
US5192232A (en) | 1992-07-13 | 1993-03-09 | Molex Incorporated | Electrical connector system utilizing thin male terminals |
US5534028A (en) * | 1993-04-20 | 1996-07-09 | Howmedica, Inc. | Hydrogel intervertebral disc nucleus with diminished lateral bulging |
DE69531638T2 (en) * | 1994-06-06 | 2004-06-17 | Osiris Therapeutics, Inc. | BIOMATRIX FOR TISSUE REGENATION |
US5716416A (en) * | 1996-09-10 | 1998-02-10 | Lin; Chih-I | Artificial intervertebral disk and method for implanting the same |
GB9714580D0 (en) | 1997-07-10 | 1997-09-17 | Wardlaw Douglas | Prosthetic intervertebral disc nucleus |
-
1995
- 1995-09-04 AT AT95306158T patent/ATE203885T1/en active
- 1995-09-04 DE DE69522060T patent/DE69522060T2/en not_active Expired - Lifetime
- 1995-09-04 EP EP95306158A patent/EP0700671B1/en not_active Expired - Lifetime
- 1995-09-06 CA CA002157634A patent/CA2157634C/en not_active Expired - Fee Related
- 1995-09-06 JP JP7229031A patent/JP2735517B2/en not_active Expired - Fee Related
- 1995-09-07 AU AU30488/95A patent/AU686855B2/en not_active Ceased
-
1996
- 1996-06-25 US US08/670,140 patent/US5976186A/en not_active Expired - Lifetime
-
1999
- 1999-09-02 US US09/388,843 patent/US6280475B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6280475B1 (en) | 2001-08-28 |
AU686855B2 (en) | 1998-02-12 |
EP0700671A1 (en) | 1996-03-13 |
DE69522060D1 (en) | 2001-09-13 |
ATE203885T1 (en) | 2001-08-15 |
CA2157634A1 (en) | 1996-03-09 |
DE69522060T2 (en) | 2002-05-29 |
EP0700671B1 (en) | 2001-08-08 |
US5976186A (en) | 1999-11-02 |
AU3048895A (en) | 1996-03-21 |
JP2735517B2 (en) | 1998-04-02 |
JPH0898851A (en) | 1996-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2157634C (en) | Hydrogel intervertebral disc nucleus | |
US5047055A (en) | Hydrogel intervertebral disc nucleus | |
EP0563332B1 (en) | Hydrogel intervertebral disc nucleus | |
EP1407729B1 (en) | Radiopaque hydrogel intervertebral disc nucleus | |
US5534028A (en) | Hydrogel intervertebral disc nucleus with diminished lateral bulging | |
USRE42837E1 (en) | Spinal nucleus implant | |
US6783721B2 (en) | Method of making an ion treated hydrogel | |
AU710417B2 (en) | Hydrogel intervertebral disc nucleus with diminished lateral bulging |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20140908 |